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About thirty years ago it was thought that the alkaline
phosphatases obtained from different human tissues were closely
similar or even identical. However, as knowledge of the
properties of these enzymes has increased, differences between
phosphatases from several human organs have been revealed in
their reaction to specific antibodies, and in enzymatic
properties such as their response to various inhibitors.
These observations were for the most part based on studies
using impure enzyme preparations, and nothing was known about
the molecular basis for these distinctions. The object of the
present study was to purify alkaline phosphatase from various
human tissues and to investigate the properties of the purified
enzymes to find out whether the differences previously reported
were genuine properties of the alkaline phosphato.se molecules
or due to the presence of impurities. In addition, it was
hoped to throw light upon the molecular origin of any differ¬
ences between the isoenzymes.
Human liver, intestinal and bone alkaline phosphatases
were purified about 2000, 1000 and 700-fold respectively,
by means of a sequence of procedures including gel-filtration
and anion-exchange chromatography. The properties of the
purified enzymes were then compared in respect of their
physical properties, catalytic properties and molecular
structure.
The physical properties studied included the molecular"
weight of the purified enzymes, their reaction to neuraminidase,
their mobility on starch-gel electrophoresis, and their rates
of inactivation by various denaturing agents. On the basis
of their molecular weight and their reaction to neuraminidase
the liver and bone enzymes were found to be similar, but were
markedly different from the intestinal enzyme. The three
isoenzymes differed in their mobility on starch gel electro¬
phoresis and in their resistance to inactivation.
'The substrate specificity of the three purified alkaline
phosphatases was investigated. Although alkaline phosphatases
were originally thought to be solely orthophosphatases, all
three enzymes were found to hydrolyse inorganic pyrophosphate
and several organic pyrophosphates. This activity was shown
to be a property of the alkaline phosphatase molecule; it was
not due to the presence of a mixture of enzymes of differing
specificities. The relative rates of hydrolysis of a range
of substrates varied with the tissue source of the enzymes.
The effect of metal ions on the enzymatic activity and the
Michaelis constants were specific for the tissue of origin.
Measurement of the catalytic centre activity showed that the
liver and intestinal enzymes differed in this respect.
The molecular structure was investigated by labelling
■52
the enzyme molecule with v P-phosphate followed by hydrolysis
of the protein so that the patterns of labelled peptides could
be compared. However, this did not yield any information
about the structure of the alkaline phosphatase molecule and
possible reasons for the failure of this experiment are
discussed.
In summary, the alkaline phosphatases from human liver,
small intestine and bone were found to differ in many of their
properties. It is concluded that there is a fundamental
difference between the enzymes, but the molecular basis of
their differences has not yet been elucidated.
ACKNOWLEDGEMENT.
It is a pleasure to acknowledge my debt to my supervisors,
Professor L.G. Whitby and Dr. D.W. Moss for their helpful
advice and wise guidance and for the encouragement that they
have given me during this period of research. I would also
like to thank my colleague, Dr. J.K. Smith for useful
discussions and Miss J. Webster, Miss E. Brotherstone and
Miss L. Reynolds for efficient technical assistance.
TABLE OF CONTENTS.
CHAPTER 1. INTRODUCTION.
1.1 Sources and Purification of Alkaline Phosphatase .. 4
1.2 Outline of the Aim of the Investigation 6
1.3 General Characteristics of the Alkaline
Phosphatase Reaction 7
1.4 The Identity or Non-identity of the Isoenzymes
of Human Alkaline Phosphatases 20
1.5 Conclusions and Aims 33
CHAPTER 2. ENZYME PURIFICATION AND ASSAY METHODS.
2.1 Measurements of Enzyme Activity 37
2.2 Enzyme Preparation 40
CHAPTER 3. PHYSICAL PROPERTIES OF THE ALKALINE PHOSPHATASES.
3.1 Molecular Weight 50
3.2 Mobility under Starch-gel electrophoresis 50
3.3 Reaction to Neuraminidase 53
3.4 Inactivation by Various Agents 55
3.5 Summary of Findings 57
CHAPTER 4. THE ENZYMIC PROPERTIES OF THE PHOSPHATASES.
4.1 Substrate Specificity of Hydrolysis Reaction 60
4.2 Effect of Metal Ions of the Hydrolysis Reaction .. 71
4.3 Kinetics of the Hydrolysis Reaction 7^
4.4 Inhibition of the Hydrolysis Reaction 81
4.5 Catalytic-centre Activity 84
4.6 Summary of Findings 90
CHAPTER 5. AN EXAMINATION OP THE MOLECULAR STRUCTURE.
5.1 Introduction 91
xp
5.2 Laoelling of Liver Phosphatase with - P-phosphate:
preliminary experiments 92
■52
5.3 Labelling of E.coli Phosphatase with y P-phosphate 95
5.4- A Second Attempt to label Liver Phosphatase 97
CHAPTER 6. DISCUSSION.
6.1 Introduction 102
6.2 Enzyme Preparation 102
6.5 Are the Alkaline Phosphatases from different
Tissues Identical? 104-
6.A The Physiological Role of Alkaline Phosphatase .. 132
BIBLIOGRAPHY 135
CHAPTER 1 INTRODUCTION
The history of enzymology can be traced back to the
discovery in 1833 by Payen and Persoz of a heat labile sub¬
stance which converted starch into sugar and which they named'
"diastase". The name "enzyme" was not coined until 1878 when
Kuhne proposed that the agents which caused fermentation and
digestion should be denoted "enzymes". Prom this beginning
over 100 years ago the number of known enzymes has grown to
about 700 (Dixon and Webb, 1964).
The first description of an enzyme which caused the
liberation of inorganic phosphate from phosphate esters was by
Suzuki, Yoshima and Takahishi in 1907, who found an enzyme in
rice and wheat bran which split phytin. This was quickly
followed by the discovery of a similar enzyme in calf liver by
McCollum and Hart (1908) and of an enzyme in cat kidney,
intestine, lung, liver and spleen which hydrolysed glycerophos¬
phate (Grosser and Husler, 1912). Since then the number of
enzymes reported as hydrolysing phosphomonoesters has increased
to 19 (Dixon and Webb, 1964). Some of these are specific for
one substrate (e.g. nucleotide phosphohydrolase, E.C.3.1.3•5•)
while others have a broad specificity (e.g. acid and alkaline
phosphatases, E.G.3»1.3.2. and 3»1»3»1.)« 2he work described
in this thesis is concerned with the non-specific phosphoric
monoester hydrolase which has a pH optimum on the alkaline side
of neutrality and is commonly known as alkaline phosphatase
(4.G.3.1.3.1.).
The first description of a phosphatase with a pH optimum
greater than 7 was made by Robison (1923) who found that extracts
of rabbit and rat bone could hydrolyse ^-glycerophosphate and
hexose monophosphate esters. This enzyme, he later found, was
concerned with bone ossification (Robison and Soames, 1924).
It was also identified in kidney, liver, spleen (Robison, 1923),
milk (Graham and Kay, 1933) and intestinal mucosa (Levene and
Dillon, 1930).
Kay (1932) suggested that the phosphatases from bone,
intestine, kidney and plasma were identical since they had many
properties in common. Bodansky (1937), however, found that
phosphatase extracted from the intestine of various species
differed from the phosphatase from bone and kidney in that the
latter were inhibited by bile acids added to the assay mixture
while the former was insensitive to them. Since then
differences with respect to inhibitors (e.g. L-phenylalanine;
Fishman, Green and Inglis, 1962), antigenic properties
(Schlamowitz and Bodansky, 1959) and sensitivity to various
denaturing agents (e.g. heat; Birkett, Gonyers, Neale, Posen
and Brudenell-Woods, 1965) have been found between the
phosphatases from different tissue sources and in different
species.
Not only are there variations between catalytically
analogous enzymes from different species and different tissues,
but, more recently, heterogeneity with respect to a given
enzyme activity within one organ has also been reported, first
of all for lactate dehydrogenase (R.C.1.1.1.27.) (e.g. hy
Wieland and Pfleiderer, 1957; Vesell and Beam, 1958; Sayre
\
and Hill, 1957) and later for alkaline phosphatase (Moss and
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King, 1962).
In 1959 Markert and. Miller coined the name "isozyme" to
define "the different molecular forms in which proteins may
exist with the same enzymatic specificity"the name "isoenzyme"
is now preferred (vtfebb, 1964). Markert and Miller (1959)
considered that, because of their broad specificity, alkaline
phosphatases could not be considered as isoenzymes, as within
each tissue there might be a family of closely related enzymes,
rather than variants of a single enzyme. The term "isoenzyme"
has subsequently been used in two senses. Firstly, to refer
to different enzyme proteins with the same enzymatic specificity
from the same species and the same tissue (e.g. Wieland and
Pfleiderer, 1962), and secondly to refer to enzymes having the
same catalytic activity prepared from different tissues of the
one species (e.g. Moss, 1964). The term is used in the latter
sense in this work. Despite their broad specificity the
alkaline phosphatases are not thought to be a family of
associated enzymes in each tissue (Landau and Schlamowitz, 1961).
1.1. SOURCES ADD PURIFICATION OF ALKALINE PHOSPHATASE.
Alkaline phosphatase has been identified in most human tissues.
Morton (1954-) found that the alkaline phosphatases of calf
intestinal mucosa and cow mammary gland were associated with
the microsomal particles and were firmly bound to lipoprotein.
Several methods for the isolation of alkaline phosphatase have
been suggested. Morton's (1950) extraction with butanol has
largely superseded the older methods of controlled autolysis
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(Albers and Albers, 1935) and tryptic digestion (Schmidt and
Thannhauser, 1943). The butanol method gave a greater yield
of alkaline phosephatase than autolysis and, although alkaline
phosphatase was thought to be resistant to trypsin, there is
the possibility of modification of the enzyme protein in the
latter procedure.
A few workers have used highly purified preparations to
examine the properties of the enzyme (e.g. Ahmed and King,
1960b; Binkley, 1961a) while others have worked with blood,
serum or tissue homogenates (e.g. Robinson and Pierce, 1964).
Contamination of the enzyme extracts with similar enzymes and
non-specific proteins and metal ions, and the consequent
vitiation of the results, makes it advisable in all enzyme
studies to use only preparations of the highest possible purity.
Table 1.1 shows the highest specific activities so far
obtained for alkaline phosphatases from a variety of sources.
No preparations from human tissues of any great purity have so
far been reported, except that of Ahmed and King (1960a).
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Table 1.1. Specific Activities of some Purified Alkaline
Phosphatases.
units: Roche units/mg. nitrogen (Roche and Bouchillaux, 1950).
Reference Specific Activity- Tissue Source of Enzyme
Morton, 1954





















* from the calculation by Binkley (1961a) to compare with his
preparation.
1.2. OUTLINE OP THE AIM QP THE INVESTIGATION.
'The aim of this work was to investigate whether or not the
alkaline phosphatases isolated from different human tissues were
identical. The general characteristics of the alkaline
phosphatase reaction (e.g. substrate specificity, kinetics,
inhibition) are discussed first and then the properties of the
isoenzymes are compared under the three headings: physical
properties, enzymic properties and molecular structure.
1.3. GENERAL CHARACTERISTICS OF THE ALKALINE PHOSPHATASE
REACTION.
The general reaction of alkaline phosphatase is the
hydrolysis of an orthophosphoric monoester with the production
of inorganic phosphate and the corresponding alcohol. By
/\ O
employing water labelled with 0, it has been shown that the
point of attack by the water on the substrate is the oxygen -
phosphorus bond (Cohn, 194-9; Stein and Koshland, 1952).
0 0
R-0-P-0H + Ho180 » R - 0 - H + H180 - P - 0 ~
1 2 1 -
0- 0
1.3.1. Substrate Specificity.
The broad substrate specificity of alkaline phosphatase
has long been recognised (Kay, 1932) and some doubt about
whether alkaline phosphatase represents a family of closely
related enzymes or one enzyme of broad specificity has been
expressed (Narkert and Ndller, 1959). Norton (1955) carried
out an extensive study of the specificity of calf intestinal
phosphatase towards the organic moiety of the substrate. All
monophosphate esters and diphosphate esters (e.g. fructose 1:6
diphosphate) were hydrolysed. This has been confirmed by
Folley and Kay (1936) with various human phosphatases; by
Schmidt and Thannhauser (194-3) with calf intestinal phosphatase;
by Garen and Levinthal (i960) with alkaline phosphatase from
E.coli; and by Trubowitz, Feldman, Morgenstern and Hunt (1961)
with human leucocyte phosphatase.
Activity towards pyrophosphates (e.g. inorganic pyrophosphate,
- 8 -
ADP and ATP) has been reported by some workers while others
have shown that their alkaline phosphatase preparations were
free from pyrophosphatase activity. Kay (1932) found 'activity
towards pyrophosphate in his preparations of alkaline phosphatase
and a highly purified preparation of calf intestinal phosphatase
of Schmidt and Thannhauser (199-3) also had pyrophosphatase
activity. However Morton (1955), using purified calf intestinal
phosphatase, found no activity towards pyrophosphates, either
organic or inorganic. This was confirmed by Portmann (1957),
also using calf intestinal phosphatase. E. coli alkaline
phosphatase was similarly found to be devoid of activity
towards pyrophosphates (Garen and Levinthal, 1960; Torriani,
1960).
However, ability to hydrolyse pyrophosphate and nucleoside
phosphates was found in alkaline phosphatase obtained from E. coli
(Heppel, Harkness and Hilmoe, 1962) and from human leucocytes
(Trubowitz et al, 1961). In each case the authors presented
evidence that the pyrophosphatase activity was a property of
the alkaline phosphatase protein, and was not due to contamination
of the preparations.
Alkaline phosphatase has no action on phosphate diesters
(Morton, 1955; Heppel et al, 1962).
1.3.2. Kinetics.
Enzymes can be characterised not only by their substrate
specificity but also by study of the kinetics of the reaction
between enzyme and substrate. Henri (1902) suggested that the
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enzyme first combined with the substrate (S) to form a complex
(ES) which then broke down to free enzyme (E) and products.
i.e. E + S v N ES
ES > E + products
Erom these equations, Michaelis and lienten (1913) derived an
expression for the equilibrium constant.
If e is the total enzyme concentration
s the free substrate (the amount combined with the
enzyme is negligible so the substrate concentration
is much greater than the enzyme concentration)
and p the concentration of ES
then the equilibrium constant, K = (e-p)s3
P
i.e. p = es
Ks + s
If k is the velocity constant of the reaction ES > E + products










Michaelis and Menten (1913) assumed in this derivation
that the equilibrium governed by K is attained very rapidly
and is maintained. The effect on the equilibrium of the
reaction for the breakdown of ES to enzyme and products was
ignored.
Briggs and Haldane (1925) derived a similar equation
based on the postulate that at any moment rates of formation
and breakdown of EG were equal.
i.e. E + S k+1 >. ES k+2 >. E + oroducts
X ' ?
k-1
pk+2 + = s(e ~ P)k+i
(The symbols have the same connotation as before)
This reduces to v = ^max
Vs + 1
where K_ = ^-1 + ^+2
m
k*+1
K , the Michaelis constant, is the value of s which is experi¬
mentally found to give half the maximum velocity. When k+£
is considerably less then k+^ then Km = .
and Vmax may be found by measuring the velocity of the
reaction at various substrate concentrations. Several methods
of plotting the results have been suggested, the best known of
which is probably that of Lineweaver and Burk (1934-), when 1/v
is plotted against 1/s. The intercept on the 1/s-axis is then
- 1/K , and the intercept on the 1/v-axis is 1/V . Anotherm' * max
method is to plot s/v against s when the x-axis intercept is
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- Km (Hanes, 1932), or to plot v against v/s when the gradient
is -Km (Hofstee, 1959).
Rolley and Kay (1935) and Ross, Ely and Archer (1951) found
that the pll optimum for alkaline phosphatase activity varied with
the substrate concentration. If velocity measurements were
made at a fixed pH and varying substrate concentration and
was calculated, then was found to vary with the enzyme
concentration used (Motzok, 1959). By making velocity measure¬
ments at the optimum for each substrate concentration this was
avoided (Motzok, 1959; Moss, Campbell, Anagnostou - Kakaras
and King, 1961a).
1.3.3. Effect of Temperature and pH.
Measurement of the velocity of a reaction at different
temperatures shows a temperature optimum. This is due to a
combination of two effects; enzyme instability and enzyme
activity. The rate of denaturation of an enzyme increases
with increase in temperature. The enzymatic activity, as
with all chemical reactions, also increases with increasing
temperature and in consequence, the velocity of the reaction
at any temperature is a balance between the rate of denaturation
and the kinetic effect of temperature on reaction rates.
Many determinations of enzyme activity are carried out at 37°G
since this is the normal human body temperature and one at
which enzymes are comparatively stable. The effect of heat on
the stability of the alkaline phosphatases is discussed later.
Generally enzymes are only active over a restricted range
- 12 -
of pH values and usually an optimum pH can be found. The
optimum may be due to an effect of pH on the stability of the
enzyme, or an effect on Vmax» or an effect on K , or may reflect
a combination of these effects. Enzymes being proteins contain
many ionisable groups and so the enzyme, the substrate, and the
enzyme-substrate complex may exist in more than one ionic form
depending on the pH. Probably only one of the forms of the
substrate, the enzyme and the enzyme-substrate complex will have
the correct ionic configuration to permit it to take part in the
reaction. The effect of pH on Vmax is produced solely by
variations in the amount of ES in the correct form. The effect
on Km is an effect on the affinity of the enzyme for the
substrate and the ionisable groups of the enzyme involved in
the catalytic action. At certain pH values the groups will
be in an ionic form less favourable for binding the substrate:
the affinity is, therefore, reduced and the Km increased. The
effect of pH on stability is considered under physical properties.
Dixon (1953a) derived a relationship between log Vrr,ov andGla.X
pH, and between pK^ and pH, whereby the ionisation constants (K)
of ES, E and S could be derived. If log Vmax is plotted against
pH, the graph which is obtained consists of linear sections of
gradient 0, 1, or 2, with short curved portions joining them
(Fig. 1.1.). If lines of the appropriate slope are drawn through
the straight line parts then the points of intersection give the
pK values for the ionisation of ES. If a gradient of 2 is
obtained then two groups of ES are ionising simultaneously.
Plots of pKffl against pH show a similar picture, but in this case
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the intersections of the straight portions are pK values for
the ionisation of E, S and ES (Fig. 1.1.). Since the ionisation
constants for the substrate can be readily obtained by- other
means, pK for the enzyme can be defined. The pKe values are
the ionisation constants of the groups of the enzyme involved
in the attachment of the substrate and, hence, in the active
site of the enzyme. By measuring pKg, it would, therefore, be
possible to identify the amino acid groups involved in the
active centre, were it not for the fact that a group may not
have the same pK value when it is combined in a protein molecule
and surrounded by other ionising groups as it does as a free
amino acid. pKg values can only, therefore, give some
indication of the amino acid group involved in the reaction.
Plots of pH against pKffi for chick alkaline phosphatase (Notzok,
1959) and for calf intestinal phosphatase (Norton, 1957) have
been published, but no similar work has been reported for the
human enzymes.
1.5.4-. Inhibition of the Hydrolysis Reaction.
i) Kinetics: Enzyme inhibition may be divided into two main
types, reversible and irreversible, depending on whether or not,
on dialysis of the inhibitor and the enzyme, the inhibition is
removed. In the case of reversible inhibition, there is set
up between the enzyme and the inhibitor an equilibrium which is
characterised by a constant, , known as the inhibitor constant.
K^ is the reciprocal of the affinity of the enzyme for the
inhibitor. The degree of inhibition with a reversible inhibitor
PH
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is dependent on the concentration of the inhibitor and is, once
equilibrium has been reached, independent of time.
On the other hand, with irreversible inhibition there is
no equilibrium and the inhibition is progressive with time,
reaching 100% inhibition if the inhibitor concentration is
greater than the enzyme concentration. This inhibition is
characterised by a velocity constant. An example of
irreversible inhibition is the action of cyanide on xanthine
oxidase, while the inhibition of cytochrome oxidase by cyanide
is reversible.
Since the inhibitors of alkaline phosphatase which have been
studied are all reversible inhibitors, the kinetics of irrevers¬
ible inhibition will not be discussed.
Reversible inhibitors may be subdivided into three main
classes - competitive, non-competitive and uncompetitive.
Competitive inhibitors, by competing with the substrate for the
active site of the enzyme, decrease the affinity of the enzyme
for the substrate and so increase the K . Non-competitive
inhibitors have no effect on K but reduce V while uncompet-
m max c
itive inhibitors affect both K and V . Mixed types ofm max J^
inhibition have also been noted,
a) Competitive Inhibition:
These are generally substances with a similar structure
to the substrate and can combine with the active site of the
enzyme, effectively blocking it, but not breaking down into
free enzyme and products. In this case the enzyme combines
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with the substrate or the inhibitor but not both. These are
called fully competitive inhibitors. A partially competitive
inhibitor is one which combines with the enzyme, not at the
active site but at a point sufficiently close to it to reduce
the affinity of the enzyme for the substrate although still
allowing the substrate to combine with the enzyme.
In the fully competitive type there are two possible
reactions of the enzyme:
E + S v - ES > E + products
E + I v ^ EI
where I is the inhibitor.




1 + Km/s (1 + i/K±)
Where is the inhibitor constant and is a measure of the
affinity of the enzyme for the inhibitor.
Again there are several ways of plotting the results. The
velocity with a range of substrate concentrations in the absence
and in the presence of an inhibitor may be plotted as 1/v against
1/s (Lineweaver and Burk, 1934)• With competitive inhibitors
V is unaffected by the presence of the inhibitor, so the
max 1
lines intersect on the 1/v-axis and the point of intersection
with the 1/s-axis is -1/Km(l + ±/K_. ) in the presence of the
inhibitor (Pig. 1.2.). Dixon (1953b) suggested measuring the
Fig. 1.2. Diagram showing Dixon's (1953b) method (A) and
Lineweaver and Burk's (193*0 method (B) of representing the




velocity at a range of inhibitor concentrations and plotting
1/v against inhibitor concentration for each substrate concen¬
tration. The point of intersection, which lies between the
two axes, has an abscissa of -K^ (Fig. 1.2.).
In the partially competitive type of inhibition the
enzyme can combine with both I and S
i.e. E + S ~ ES ;> E + products (P)
E + I f EI
ES + I k EIS + P
EI + S v EIS * E + P
Since, by definition, the inhibitor affects only and not
V
_ . the velocity of breakdown of EIS must be the same as thatKlclX
for ES, and the overall velocity is the sum of the two separate
velocities. When the method of Dixon (1953b) is used to
represent the results of this partially competitive type of
inhibition, the plots are similar to the fully competitive type,
but at high inhibitor concentrations the velocity may increase
more rapidly than would be expected, due to the fact that the
inhibitor concentration is greater than the enzyme concentration
and the enzyme is saturated with inhibitor and the inhibition has
reached a maximum value.
b) Non-competitive inhibition;
These inhibitors combine with the enzyme at a point some way
removed from the active site; they have no effect on the affinity
of the enzyme for the substrate, but affect the velocity of the
- 17 -
breakdown of the enzyme - substrate complex. This type of
inhibition may also be subdivided depending on whether or not
EIS breakdown occurs. In the former case it can be proved
that
V
v - = max
(1 + i/k±) (1 + K/s)
If the results are plotted by the method of Dixon (1953b), the
i
point of intersection lies on the x-axis and is equal to -KL
(Fig. 1.2.). When EIS does break down, the velocity of the
reaction is the sum of the velocities of the two reactions,
ES » E + P and EIS >EI + P. Calculation of by the
usual methods is not possible in this case.
It is also possible to have a "mixed" type of inhibition.
In this case, the inhibition is a combination of partially
competitive and one of the two types of non-competitive
inhibition and if the results are plotted by the method of
Lineweaver and Burk (1934) the lines do not intersect on
either axes nor are they parallel.
c) Uncompetitive Inhibition:
In this case the inhibitor can combine only with the ES
complex and it can be shown that
V
v = max
Vs + 1 + 1/Ki
This type of inhibition is characterised by parallel lines in
the double reciprocal plots of Lineweaver and Burk (1934) and
in the Dixon (1953b) plots (Fig. 1.2.).
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ii) Examples of Inhibitors: Some inhibitors of alkaline phosph¬
atase appear to affect all the isoenzymes while others are
specific for the enzyme from one tissue source. Examples of
the former group are the metal ion complexing agents, some
amino acids, and some monophosphate esters. EDTA and cyanide
inhibit alkaline phosphatases from a variety of animal sources
by a non-competitive mechanism (e.g. Schmidt and Thannhauser,
194-3; Plocke, Levinthal and Vallee, 1962). Human leucocyte
and placental phosphatases are also inhibited by metal-binding
reagents (Ahmed and King, 1960b, Trubowitz et al, 1961).
Phosphate, as the product of the hydrolysis reaction, acts as
a competitive inhibitor (Lazdunski and Ouellet, 1962). Other
monophosphate esters and arsenate, which has a chemical
structure similar to phosphate, also inhibit competitively the
enzyme from E. coli (Garen and Levinthal, 1960). Bodansky
(194-8) found that many amino acids inhibited alkaline
phosphatase activity.
Inhibitors specific for certain isoenzymes are discussed in
section 1.4.2.
1.3.5. Effect of Metal Ions.
Although some enzymes are unaffected by metal ions, many
others are markedly activated or inhibited. The effect of a
particular metal varies from enzyme to enzyme and from substrate
to substrate. Concentration of the ion, pH of the solution,
and even the purity and age of the enzyme solution alter the
effects of the metal. The actions of the metal ions may,
therefore, be very complex and the precise method and conditions
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of treatment of the enzyme with metals and full details of the
source of the enzyme and the method used for its preparation
are necessary if effects observed by different workers,are to
be satisfactorily compared.
Plots of metal concentration against the velocity of the
enzyme reaction resemble those for substrate concentration,
and a constant (K ) analogous to the Michaelis constant can be
obtained. However the interpretation of is not simple.
There are several ways in which an enzyme may be activated
by a metal. The metal may form an essential part of the active
centre of the enzyme, or it may act as a link between the enzyme
and the substrate. Although not actually involved in the
enzymic reaction a metal may produce a change in the equilibrium
constant by a combination with, and removal of, the products of
the reaction or an inhibitor present in the enzyme preparation.
Alkaline phosphatase, like most other enzymes acting on
phosphorylated substrates, is activated by magnesium ions.
Most methods of assay include the addition of Mg^+ to the assay
mixture (Clark and Porteous, 1965). This activation is also
produced by other divalent ions, e.g. manganese and to a lesser
extent by calcium, zinc and cobalt. In each case the ions
activate at low concentration but are strongly inhibitory at
higher concentra.tions (Morton, 1955; with calf intestinal
phosphatase). The only alkaline phosphatase reported as not
being affected by magnesium ion's is the enzyme obtained from
E. coli (Binkley, 1961b). Alkaline phosphatases from different
sources have been found to show different degrees of activation
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by magnesium ions (e.g. by Ahmed, Abul-fadl and King, 1959).
This may be due to differences in the enzymes, or to variations
in the amount of the endogenous magnesium still remaining after
purification.
When alkaline phosphatase from E. coli is dialysed against
metal chelating agents there is progressive loss in activity,
which can be restored with Zn^+ and to a lesser degree by other
divalent ions (e.g. Plocke and Vallee, 1952). This evidence,
together with metal analysis (Engstrom, 1951b) has been
interpreted as an indication of the presence of zinc as an
essential part of the active site of the enzyme.
The metal ion inhibitions which have been reported are
generally with high concentrations of Ca^+, Zn^+ and Co^+.
Beryllium, unlike these metals, inhibits at high concentrations
but does not activate at a lower concentration (Grier, Hood and
Hoagland, 194-9).
1.4-. THE IDENTITY OR NON-IDENTITY OF THE ISOENZYMES OF HUMAN
ALKALINE PHOSPHATASES.
In considering the properties of alkaline phosphatase,
the question arises whether or not the isoenzymes from different
tissues are identical. If they are not, then to what is the
difference due? This problem is not only of academic importance,
but it has also clinical significance. An increase in the
serum alkaline phosphatase activity may be due to a number of
causes e.g. infective hepatitis, obstructive jaundice, cirrhosis
of the liver, Paget's disease, hyperparathyroidism, etc. If
alkaline phosphatases are not identical, a simple method of
- 21 -
distinguishing them in serum would facilitate the identification
of the tissue source of serum alkaline phosphatase in disease
and so aid the diagnosis of the cause of the elevation <in
enzyme level.
The possibility that all the alkaline phosphatases from
different tissues are identical was suggested by Kay (1952)
when he studied the alkaline phosphatases from bone, intestine,
plasma and kidney and found that they all had the same optimum
pH, all hydrolysed inorganic pyrophosphate, were all stimulated
by the same concentration of magnesium ions, all had the same
relative rates of hydrolysis with a series of substrates, and
all synthesised phosphoric esters. Since then, however,
various workers have found properties of alkaline phosphatase
which indicate that there may be differences between the iso¬
enzymes. These will be discussed under three headings -
namely, physical properties, enzymic properties and molecular
structure.
1.4.1. Physical Properties.
a) Molecular weight: The molecular weights of proteins may be
determined by various means, the two most frequently employed
for alkaline phosphatase being sedimentation in an ultra-
centrifuge, and filtration through a column of "Sephadex G-200"
when the elution volume is compared with values obtained for
proteins of known molecular weight. Table 2.2. shows values
for human alkaline phosphatases. (Those from animal sources
































Boyer (1963) found that the behaviour of the human kidney
and placental enzymes on ultracentrifugation was identical.
A failure to separate the phosphatases from placenta, liver,
bone and intestine on "Sephadex" confirmed the similarity of
their molecular weights (Birkett et al, 1965).
b) Electrophoresis; Various supporting media have been used
in zone-electrophoresis of alkaline phosphatase. Ahmed and
King (1960a) used paper as supporting medium for electrophor¬
esis in their method for purifying placental alkaline phosphat¬
ase. A difference between the mobility of bone and liver
alkaline phosphatase on paper electrophoresis was found by Nath
and Ghosh (1964). Agar-gel electrophoresis of alkaline
phosphatase was developed by Stevenson (1961), and character¬
istic bands for liver and bone isoenzymes were demonstrated,
the bone enzyme migrating slightly more slowly than liver
phosphatase at pH 8.4 (Haije and DeJong, 1963).
Starch-gel, however, is the most frequently used medium
for electrophoretic separation of enzymes, and there are
numerous reports of electrophoretic separation of alkaline
phosphatase in serum and in tissue extracts using starch-gel
as the supporting medium. Both the molecular size and the
charge on the molecule affect the rate of migration of the
ion in the gel (Smithies, 1962). There is some variation in
the number of bands of alkaline phosphatase activity seen after
starch-gel electrophoresis of human serum at pH 8.6. Boyer
(1961) reported 16 bands which could be divided into 6 main
zones, though not all were observed in any one individual,
while Kowlessar, Haeffner and Riley (1961) and Kreisher, Close
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and Fishman (1965) found two main bands of activity in normal
serum. This variation was partly due to a difference in the
state of the patient from whom the serum was taken and partly
to the technique of starch-gel electrophoresis.
The more cathodic of the two bands seen in normal serum
after starch-gel electrophoresis has been identified as
originating from the intestine, by testing for its- sensitivity
to L-phenylalanine, by examining its resistance to thermal
denaturation (Kreisher et al, 1965), and by its reaction with
anti-intestinal phosphatase antibody (Boyer, 1961). The
occurrence of this component in the serum of certain individuals
is associated with the ABO blood groups (Arfors, Beckman and
Lundin, 1965).
The more anodic band is from the liver (Hodson, Latner and
Raine, 1962). In cases of bone disease, which caused an
elevated alkaline phosphatase level, a band of activity slightly
cathodic to the liver band was seen (Hodson et al, 1962).
Since 'the difference in migration between the liver and bone
enzyme is small, many workers have found similar migration
(e.g. Ghiandussi, Greene and Sherlock, 1962) and some have
stated that the main band in normal sera originated from bone
(e.g. Kowlessar et al, 1961). Antibody experiments also
supported this (Schlamowitz and Bodansky, 1959). Boyer (1961)
found that three of the six main zones of activity only occurred
in pregnancy and were presumably placental in origin. Electro¬
phoresis of placental alkaline phosphatase has been reported to
produce several different distributions of activity, which
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appear to be genetically determined (Robson and Harris, 1965).
Electrophoresis of tissue extracts has shown that there
are several bands for each tissue. Moss and King (1962) found
that liver alkaline phosphatase had three or four bands;
intestinal phosphatase, two; kidney phosphatase, three; and
bone phosphatase, two. In each case one component migrated
slowly, parallel with the lipoprotein fraction of the serum
proteins. Urinary alkaline phosphatase migrated more rapidly
than the liver or kidney enzymes (Butterworth, Moss, Pitkanen
and Pringle, 1965). The zone of activity associated with
kidney alkaline phosphatase is broad but the leading edge is
approximately parallel with that of the liver. The variation
in the appearance of the minor bands can be due to different
methods of preparation (Moss, 1962) or to degradation (Moss
and King, 1962; Moss, 1965). Moss and King (1962) found no
difference between the different bands from one tissue source
with respect to values and heat stability, and they suggested
that there was a single alkaline phosphatase in each tissue,
the main zone on starch-gel electrophoresis being free enzyme
and the other bands arising from aggregation or disaggregation
of the free enzyme or its association with protein fractions.
c). Reaction to Neuraminidase: Neuraminidase (E.G.3.2.1.18.)
catalyses the removal of sialic acid residues from mucoproteins
(Gottschalk, 1958), and Robinson and Pierce (1964-) tested its
effect on serum alkaline phosphatase. Starch-gel electro¬
phoresis of serum produced a number of bands of activity,
varying from one to four with different sera, and they found
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that all but one of these was altered by treatment with neura¬
minidase. The unaffected band of alkaline phosphatase was
inhibited by L-phenylalanine, and they concluded that ft was
of intestinal origin.
d) Denaturation of Various Agents: Many processes and agents
will cause a change of an enzyme from the "native" or active
state into a "denatured", inactive form. Physical agencies
such as X-rays, ultraviolet light, heat, and violent shaking
will cause denaturation. Some organic solvents, extremes of
pH and strong solutions of urea, salicylate and guanidine salts
also inactivate. Denaturation is generally irreversible being
accompanied by loss of enzyme activity; it represents a more
disordered arrangement of the protein molecule, reflected by
changes in the physical properties of the enzyme, e.g. changes
in the isoelectric point, the solubility in water, and the
reaction to specific antibodies.
Urea denaturation: High concentrations of urea have been known
for some time to exert a powerful action on proteins by breaking
of the hydrogen bonds which maintain the secondary, tertiary and
quaternary structure of the molecule; urea is often used to
break molecules into subunits. Generally, if the urea
concentration is less than about 4M (at neutral pH) there is
only a reversible inhibition of enzyme activity; but at higher
concentrations a reversible denaturation occurs (Steinhardt and
Beychok, 1964). Urea has been shown to produce two such effects
on human alkaline phosphatases and their isoenzymes. The
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concentration of urea at which the inhibition changes from
reversible to irreversible varies with the isoenzyme, the
placental enzyme being the most stable and the bone enzyme
the least stable (Birkett et al, 1965). Callaghan and Martin
(1962 and 1965) found a similar critical value for the effect
of urea on albumin and globulin and interpreted the effect of
high concentration of urea as being due to the rupture of
hydrogen bonds and consequent unfolding of the protein molecule.
Heat denaturation: Enzymes lose activity slowly at room temp¬
erature, but the rate of denaturation increases rapidly with
increase in temperature and is also time dependent. Consider¬
able variation between the isoenzymes of alkaline phosphatase
has been found with respect to their heat stability. The
enzyme preparations of Moss and King (1962) from human tissues,
in order of increasing stability at 55°0 and pH 7.0, were bone,
kidney, intestine and liver alkaline phosphatase, the time taken
for the activity to fall to 50% of the original activity being
8 minutes for the bone enzyme and 18 minutes for the liver
phosphatase. Biliary alkaline phosphatase is more stable than
the bone and liver enzymes (Posen, Neale and Clubb, 1965), while
the placental enzyme is much more resistant to heat - it is
unaffected by heating to 56° for 30 minutes (Neale, Clubb,
Hotchkis and Posen, 1965).
Acid denaturation: Reduction of the pH of an enzyme solution
will generally cause loss of activity which may or may not be
recovered when the pH is readjusted to neutrality, depending on
the pH and the length of time of inactivation.
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Comparisons of the effect of low pH on human alkaline
phosphatases have not been reported. With E. coli phosphatase,
however, treatment with acid below pH 3.0 causes the enzyme to
dissociate into two inactive subunits (Schlesinger and Barrett,
1965).
e) Immunological Properties: A general method of distinguishing
protein molecules is by the immune response. Repeated injection
of a foreign protein into a suitable animal (e.g. rabbit or horse)
causes the production of an antibody to that protein. These
antibodies, which are V-globulins, are specific to the injected
protein and will react only with the injected protein (apart
from possible cross-reactions with proteins closely resembling
the antigen) causing, under appropriate conditions, co-precipit¬
ation. This provides a means of distinguishing proteins, and
hence enzyme molecules, not by their catalytic activity but by
the structure and conformation of the protein chain. Anti¬
bodies to alkaline phosphatase were first made by Schlamowitz
(1958) for the enzyme from dog intestine, and later by Schlamo¬
witz and Bodansky (1959) for human alkaline phosphatases.
They found that the antibody to human intestinal phosphatase
precipitated only human intestinal enzyme and not the bone,
kidney or liver enzymes. Their antibody to bone phosphatase,
however, reacted with liver, kidney and bone phosphatases and
to a lesser extent with the intestinal enzyme. They concluded
that, although it appeared that liver, bone and kidney enzymes
were immunologically similar and all differed from the intestinal
enzyme, it could be that their bone preparation contained small
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quantities of the liver and kidney enzymes and that antibodies
to these were also being produced. Nisselbaum, Schlamowitz
and Bodansky (1961) confirmed that the anti-bone antibodies
precipitated the liver and kidney enzymes. Boyer (1963)
suggested that there were three antigenic classes of alkaline
phosphatase; group one consisting of liver, bone, spleen and
the major component of phosphatase activity in kidney; group
two consisting of intestinal phosphatase and the minor kidney
component; and a third group consisting of the placental
enzyme, which he considered to be immunologically different
from all the others.
1.4-.2. Bnzymic Properties.
Some variation in substrate specifically between human
phosphatases was found by Landau and Schlamowitz (1961). The
relative rates of hydrolysis for several monoesters by the
intestinal enzyme differed from those for the phosphatases from
liver, bone, spleen and kidney. They were, however, unable to
find a clear-cut difference between the Michaelis constants
of these enzymes with ^-glycerophosphate as substrate. On the
other hand, Moss et al (1961a)', using /5 -naphthyl phosphate,
found that the isoenzymes from tissue homogenates of liver,
bone, kidney and intestine had different values. In the
serum of patients with elevated alkaline phosphatase activities
due to disease of the liver, the of the phosphatase resembled
the value for the liver isoenzyme, whereas in patients with
raised activities due to bone disease, the K resembled the7 m
- 30 -
value for bone phosphatase. In cases where bone and liver
phosphatases both contributed to the elevated serum alkaline
phosphatase activity then the had an intermediate value
(Moss, Campbell, Anagnostou - Kakaras and King, 1961b).
Distinction between the isoenzymes has also been made on
the basis of the effect of certain inhibitors on the enzyme
reaction. Two inhibitors which are organ-specific are the
bile acids'and L-phenylalanine. In 1937 Bodansky showed that
preparations of intestinal enzyme from rat, rabbit, cat and
man were unaffected by bile acids, while extracts from bone
and kidney \\rere inhibited.. This was the first evidence that
the phosphatases from different organ sources were not identical.
Fishman et al (1962) found that L-phenylalanine was a specific
inhibitor of the intestinal phosphatase of rat, while the bone,
blood, lung, liver and kidney phosphatases were unaffected.
The D-isomer of phenylalanine had no inhibitory effect.
L-phenylalanine was later shown to be a specific inhibitor
of human intestinal phosphatase also (Fishman, Green and
Inglis, 1963). Derivatives of phenylalanine (e.g. formyl
phenylalanine) and other isomers (e.g. /S-phenyl-^-alanine and
<* -phenyl-/S-alanine) did not inhibit (Fishman et al, 1962).
1.4.3. Molecular Structure.
A study of the isoenzymes at a molecular level should
indicate whether the physical differences between them are due
to differences in basic structure or to differences in non¬
protein constituents of the molecule.
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otructure of the protein molecule and the active centre: Attempts
have not yet been made to elucidate the primary structure of any
of the phosphatases.
Various methods have been used for the identification of
the different groups in the active centre of enzymes. Firstly,
by measuring the pK values of the groups in the enzyme which
react with the substrate, and by deducing which amino acids are
involved. The kinetics of this have already been discussed.
Morton (1957) presented evidence based on kinetic experiment
that the phenolic group of tyrosine might be in the active site
of calf intestinal phosphatase. However, he does suggest that
the £ - amino group of lysine might be involved since the two
groups have similar pK values. Although this method is valid
as a means of characterising the different isoenzymes, it is
open to criticism as a means of identifying amino acid residues
in the active centre, since the presence of adjacent groups can
profoundly affect the pK of an ionisation as compared with the
pK for the free amino acid.
A second method involves inactivation of the enzyme with
specific chemical reagents. Lazdunski and Ouellet (1962)
found that reagents which were specific for sulphhydryl groups
inhibited the alkaline phosphatase from calf intestine. This
inhibition could be reversed on addition of cysteine. They
concluded that there was a sulphhydryl group in the active
centre of the enzyme, and that it was involved in the enzymic
reaction.
A third method is based on partial degradation of the
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enzyme molecule, either by removal of parts of the peptide
chain followed by testing to find out whether enzymic activity
still remains or has been lost, or by first labelling^the
active centre and then examining the fragments of degradation
to find the label. The former method has been employed by
Anfinsen (1956) on ribonuclease (E.C.2.7-7.16.), and the latter
method has been applied to many enzymes, using an organophos-
phorus compound as label. This organophosphate reacts with
esterases to give permanently bound phasphoryl groups at the
active centres of these enzymes (Adrian, Feldberg and Kilby,
194-7).
More recently, isotopically labelled substrates have been
employed to label the active centre before degradation (Fiilstein
and Sanger, 1961; Naughton, Sanger, Hartley and Shaw, 1960).
This method has been applied to the alkaline phosphatase from
E. coli by Filstein (1964), who effected the incorporation of
phosphate labelled with an{^ found that the label was
attached to a serine residue lying between aspartic acid and
alanine residues. The alkaline phosphatase from Serratia
marscescens has a similar sequence around the active serine
residue (Zwaig and Fiilstein, 1964), and the same sequence has
been found for calf intestinal phosphatase (Engstrom, 1964b).
Since the serine residue can be isolated with the phosphate
attached the linkage must be covalent.
Very little is known about the active centre of human
alkaline phosphatase though it may be inferred that, since
such widely varying enzymes as calf intestinal and E. coli
phosphatases have the same sequence in the active centre,
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human phosphatases are likely to be similar.
Non-protein content: Metal ions not only activate the enzyme
\
reaction but are also intimately involved in the enzyme
structure. Since the zinc concentration increases with
purification of the enzyme, and metal chelating agents inhibit
the purified enzyme, Plocke et al concluded that the E. coli
phosphatase contained zinc (Plocke and Vallee, 1962; Plocke,
Levinthal and Vallee, 1962). The protective effect of
orthophosphate against EDTA inhibition, and the fact that
orthophosphate is a competitive inhibitor of phosphatase
action, indicates that the metal ion is at the active centre
of the enzyme molecule (Garen and Levinthal, 1960). Evidence
that zinc ions are essential for enzymic action has been
reported with human leucocytes (Trubowitz et al, 1961), with
calf intestinal phosphatase (Engstrom, 1961a), and with swine
kidney phosphatase (Mathies, 1958).
1.5. CONCLUSIONS AND AIMS.
If all the known properties are taken into consideration,
it would appear that human alkaline phosphatases are not all
identical. There are three enzymic properties in which the
isoenzymes have been found to differ: relative rates of
hydrolysis of different substrates; Michaelis constants;
and reaction to certain inhibitors. There are also differences
in four physical properties; mobility on starch-gel electro¬
phoresis; reaction to neuraminidase and denaturing agents;
and antigenic properties. On the basis particularly of the
effect of neuraminidase, the reaction to inhibitors, the
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relative rates of hydrolysis with different substrates and
the antigenic behaviour, the phosphatases can be divided into
intestinal and non-intestinal groups, the latter group comprising
the liver,bone, kidney and possibly the spleen enzymes. How¬
ever, the Michaelis constants, the starch-gel electrophoresis
patterns and the reaction to denaturing agents show further
differences between the isoenzymes, including those in the
non-intestinal group. The placental enzyme appears to be
different from both the intestinal and non-intestinal groups
of phosphatases with respect to its antigenic properties and
its heat stability.
Since in the earlier investigation of these properties,
serum or relatively impure enzyme preparations were used for
the most part, there was a possibility that these variations
in properties reflected differences in contaminants isolated
concomitantly with the phosphatase, and were not due to
differences in the enzyme molecule itself. To establish
whether the differences between the isoenzymes were real, it
would be necessary to reinvestigate the properties using
purified enzyme preparations.
If the isoenzymes are not identical and the differences
cannot be accounted for by contaminants present in the enzyme
preparation, the basis of their non-identity then requires
explanation. Differences could occur, for instance, in the
non-protein part of the molecule (e.g. neuraminic acid content),
or in the primary structure, or in the conformation of the
protein chain or chains.
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The aim of this investigation was, therefore, firstly to
purify alkaline phosphatase from several different human
tissues and then establish whether these alkaline phosphatases
were identical, by studying the properties of the purified
enzymes. If differences were found, the aim was to elucidate
the molecular basis of these differences.
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CHAPTER 2. ENZYME PURIFICATION AND ASSAY METHODS.
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2.1. MEASUREMENT OF ENZYME ACTIVITY.
2.1.1. General method of assay.
\
In order to be able to follow the progress of enzyme
purification at all stages a rapid and reproducible method of
measuring the enzyme activity is necessary. Alkaline
phosphatase hydrolyses monophosphates with release of inorganic
phosphate. Either the phosphate or the organic group may be
measured and in the literature both methods are described,
the methods for measuring phosphate have the advantage that
they can be used for any substrate, but have the disadvantage
that the measurement of phosphate is not simple and generally
involves the addition of several reagents consecutively.
Choice of Substrate: The first substrate to be used was
,6-glycerophosphate by Robison (1923) and by Demuth (1925) who
measured the inorganic phosphate released. King and Armstrong
(1939-) suggested phenylphosphate as a substrate with the measure¬
ment' of the phenol produced. Other assays which have been
used are the measurement of phenolphthalein liberated from
phenolphthalein diphosphate (Huggins and Talalay, 199-5), p-
nitrophenol from p-nitrophenyl phosphate (Bessey, Lowry and
Brock, 199-6), -naphthol from o<-naphthyl phosphate (Moss,
1960) and 9—umbelliferol from 9—umbelliferyl phosphate
(Fernley and Walker, 1965). With each of these the organic
moiety is readily measured.
p-nitrophenyl phosphate (pNPP) was chosen for the present
work because the p-nitrophenol (pNP) produced is easily
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measured in the presence of unaltered substrate. In alkaline
solution p-nitrophenol is yellow with a maximum absorbance at
4-04-mp, while p-nitrophenyl phosphate is colourless and has a
maximum absorbance at 512 mp. The molar absorptivity of p-
nitrophenol was found experimentally to be 17«7 x 1Cr at pH
values greater than 9.5. This compares well with Jacobsson's
(1960) value of 18 x 10^. Enzymatic activity is expressed as
pmoles substrate hydrolysed per min. per ml. of enzyme solution
under the conditions of assay used.
Buffer system: The carbonate-bicarbonate buffer (pH 9.9) of
Delory and King (194-5) was used. Other buffers in general
use for alkaline pH (e.g. borate, glycine) were not used since
they have been reported to inhibit alkaline phosphatase activity
(Delory and King, 194-5). The optimum pH varies with the
concentration of the substrate (Ross et al, 1951)? but, in
accordance with the general assay methods for alkaline
phosphatase, the enzyme was measured at pH9.9 with a 2mM
substrate concentration (See e.g. King and Armstrong, 1954-).
The buffer was prepared by mixing equal quantities of 0.1N
sodium carbonate and 0.1N sodium bicarbonate. The pH of the
buffer was found to decrease slowly with time and it was,
therefore, checked each day before use on a Radiometer pH
meter fitted with a glass electrode.
Magnesium ions have been found to stimulate alkaline
phosphatase activity at low concentration. In order to
eliminate the effect of varying amounts of residual magnesium
-Pr¬
ions in the preparation, a constant amount of magnesium was
added to the assay solution. A concentration of was
found to be optimal. The effect of magnesium ions on
alkaline phosphatase activity is examined in detail in section
4.2.1.
Amount of enzyme added; 20 to 100 jil of enzyme solution (or
diluted enzyme solution) were added per assay and the time of
incubation was generally five minutes. The velocity of the
reaction is linear up to about 20 min.
Summary of method: 1ml. of 0.1N carbonate-bicarbonate buffer
containing 10mM magnesium chloride and an appropriate amount
of enzyme solution were preincubated at 37° for about five
minutes. 1ml. of prewarmed 4mfl pNPP was added and after a
measured time interval 1 ml. 0.4N NaOH with 0.02il ivDTA was
added to terminate the reaction. The addition of KDTA prevents
the precipitation of magnesium hydroxide. The absorbance of
the solution was read at 400 mp. in a spectrophotometer. In
a few cases the initial velocity was determined by continuous
measurement in a direct recording spectrophotometer; Gilford
2000. This general method was used for the measurement of
activity throughout the preparative stages. Modifications
for kinetic studies are reported at the appropriate point.
2.1.2. Other methods of assay.
When studying the substrate specificity of the enzyme it
was necessary to have a method of assay which depended upon
measurement of the inorganic phosphate released. Two different
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methods were used, both based on the reaction of ammonium
molybdate with inorganic phosphate and the reduction of the
phosphomolybdic acid formed to molybdenum blue. The- method
of Delsal and Manhouri (1958) uses p-methylamino-phenol
sulphate (rhodol) as the reducing agent. The enzymatic
reaction is terminated with 2 ml 2.3M acetate buffer (pH 9-.0)
containing copper ions and then 0.5 ml. 5?^ ammonium molybdate
and 0.5 ml. rhodol solution are added. The inorganic phos¬
phate in a standard of known phosphate content is measured
in parallel. The molybdenum blue complex required about 10
min. to form after the addition of the rhodol and was only
stable for a further 20 min.
+ m
In some of the later experiments the .method of Baginski
Foa and Zak (1967) was employed; this uses ascorbic acid as
reducing agent. The reduced phosphate - molybdate complex
is stable for 29- hours and any phosphate released subsequent
to the addition of the colour reagent has no effect on the
intensity of the final blue colour since one of the reagents,
arsenite-citrate, complexes with the excess molybdate. This
method proved to be more sensitive and more accurate than that
of Delsal and Manhouri (1958).
2.2. ENZYME PREPARATION.
2.2.1. Extraction and Fractionation.
Specimens of human liver, small intestine and rib with
no gross evidence of disease were obtained within 29- hours of
death and stored at -20° until extraction. Eight to twelve
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livers (wet weight 8-12 kg.) or about twelve intestines (wet
weight 5 kg.) were washed with tap water, minced and then
extracted by a modification of Morton's (1950) butanol-- method.
In a pilot experiment the tissues were extracted with various
proportions of water and n-butanol, the highest yield of enzyme
being obtained when the ratio of water to butanol was 2:1.
The minced tissues was, therefore, stirred for about 1 hour in
2 litres of water and 1 litre of n-butanol/kg. wet weight of
tissue and then centrifuged. The fat layer and the butanol
phase, which contained no enzyme activity, were discarded and
the aqueous layer containing the enzyme was decanted for
subsequent purification.
About twelve pieces of rib were broken, while still frozen,
into small fragments (wet weight about 600g.). The method of
Albers and Albers (1955) which involves autolysis in chloroform
and water and the butanol method of Morton (1950) were compared.
The latter gave a higher yield of enzyme activity. The bone
fragments were, therefore, stirred in a 2:1 mixture of water and
n-butanol for about 3 hours. The mixture was centrifuged and
all but the aqueous layer discarded.
The enzyme solution from each tissue was then cooled and
fractionated with acetone at -1°. Pilot experiments with small
quantities of butanol extract were carried out to ascertain the
amounts of acetone required to give an 80-90% yield of enzyme
with the maximum increase in specific activity. Concentrations
of acetone used in the full-scale extraction are shown in Table
2.1. The protein precipitate was separated by centrifugation,
dissolved in 0.01M tris-HCl buffer, pH 7-7, and dialysed
- 4-2 -
against this buffer to remove the acetone which would otherwise
have interfered with the next stage of purification. Since
acetone tends to cause inactivation of the enzyme, the
solution was kept at 0° throughout the procedure.
The enzyme solutions were then fractionated with ammonium
sulphate (AnalaR grade) at room temperature. The optimum
fraction for each tissue was again found by pilot experiments.
(Details of quantities are given in Table 2.1.). The protein
precipitates were separated by filtration or centrifugation
and dissolved and dialysed against 0.01M tris-HGl buffer.
The orthophosphatase activity was assayed in each fraction
after acetone and ammonium sulphate fractionations and the
protein content was measured by the extinction of the solution
at 280 mp; A 230" = ^as keen taken as equivalent to a
protein concentration of 1mg./ml. (Warburg and Christian, 194-1).
A reversal of the order of the acetone and ammonium sulphate
fractionations resulted in lower yields and smaller increases
in specific activity. These two procedures increased the
specific activity of the enzyme 10-20 fold (See Table 2.1.).
2.2.2. Gel filtration.
Sephadex G-200 (Pharmacia AB, Uppsala, Sweden) was swollen
in distilled water for about 24- hours and the "fines" removed
by decantation. The gel was packed under gravity in columns
100 x 3cm. diameter or, for larger quantities of enzyme, 90 x
8.8cm. The buffer, 0.0111 tris-HCl pH 7*7 with 0.111 NaCl and
0.1% n-butanol as a preservative, was pumped upwards through
the column. The effluent fractions (10-25 ml. depending on
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the size of the column) were collected in a fraction collector.
The enzyme solution after ammonium sulphate fractionation was
concentrated by dialysis against "carbowax" solution (polyethy¬
lene glycol) and pumped on to the column. The rate of flow
was between 1 and 4- ml./hr./sq. cm.
The orthophosphatase activity and the protein concentration
of the effluent fractions were measured. Typical separations,
are shown in Figs. 2.1. to 2.3. Tf the -^^rnp. ^ransmittance
of the effluent prior to collection was monitored in an
absorptiometer, a trace consisting of three or four "protein"
peaks was obtained, the alkaline phosphatase activity coming
between the first two. On some columns a small peak of
enzyme activity (about 10-20^ of the total activity) with
approximately the same effluent volume as the first protein
peak, occurred. This fraction was mainly associated with
the slow moving band on starch-gel electrophoresis (see section
3.2.).
On the small column the maximum sample volume for good
resolution was about 5 ml. while for the larger column 6g.
protein in 100 ml. buffer was the maximum load. Loss of
activity on the gel filtration columns was of the order of
10/t, but after selection of the central portion of the peak
and concentration against "carbowax", the overall yield was
only about 60%. There was little difference in yield whether
the columns were run at 4° or at room temperature. Gel-
filtration increased the specific activity of the enzyme
about 10-fold. When the leading and trailing edges of the
main enzyme peak were concentrated separately and rerun on










































































Sephadex G-200 the elution volumes were unaltered. Each
isoenzyme is, therefore, homogeneous with respect to molecular
size.
2.2.3. Ion-exchange chromatography.
The enzymes were submitted to cation-exchange chromato¬
graphy on cellulose phosphate pH6.0, and anion-exchange chro¬
matography on DEAE-cellulose at pH 6.8, 7-7 and 9.0. The
highest yields and greatest increase in specific activity was
obtained on DEAE at pH 7.7.
DEAE-cellulose (Whatman No. 11 or No. 52) was soaked in
distilled water, then treated consecutively with 0.5M HC1 and
0.5T1 NaOH and equilibrated with 0.01N tris-HOl, pH 7.7. The
column used for the liver and intestinal phosphatases measured
90 x 2.5 cm. diameter; but for the bone phosphatase a column
30 x 2.5 cm. was used since there was considerable loss of
activity on the longer column. The cellulose was packed
under gravity and the sample (the concentrated effluent from
gel filtration), was applied to the top of the bed. 50 to
100 ml. starting buffer (dilute tris-HOl, pH 7.7) was passed
through the column and the enzyme eluted with an increasing
concentration of NaCl. As 2 litres of buffer passed through
the 90cm. column the salt concentration was gradually increased
from 0 to 0.5^ NaCl while on the 30cm. column the sn1 t gradient
was 0-0.5M NaCl over 1 litre. In both cases gradients of
0-0.3^1 were- used latterly. These gave broader peaks of
enzyme activity, but an increase in specific activity.
Effluents were collected as before and assayed for phosphatase
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activity and protein content (Fig. 2.4—2.6). Since at low
salt concentrations the enzyme is adsorbed on to the exchanger,
there is theoretically no limit to the volume in which the
sample may be applied to the column. For good separation, a
volume of about 30 ml. (protein concentration; 0.1g./ml.) was
found to be the maximum load, but less protein was generally
applied.
Enzyme recoveries as low as 25% were occasionally found
with the liver and intestinal phosphatases. Pre-treatment
of the DEAE-cellulose with buffer containing 0.1mM zinc and
inclusion of zinc in the elution buffer increased the yield
to about 70%. Alternatively, addition of Zn^+ to the assay
mixture increased the activity of the enzyme fractions from
the columns. This loss of activity was attributed to removal
of Zn^ from the enzyme during chromatography. On the short
columns the recovery of the bone phosphatase was not increased
when the column was washed with buffer containing zinc ions nor
was the activity of the effluent fractions increased when the
metal was added to the assay system.
On anion-exchange chromatography at 4-° overall yields of
about 50% were obtained for the liver and intestinal phosphat-
aes when zinc ions were included in the buffer and for the
bone phosphatase both in the presence and absence of zinc:
at room temperature the yields were considerably reduced.
The increase in specific activity was 3 "to 5-fold. If anion-
exchange chromatography preceeded gel filtration the overall
yield of the two procedures was lower.
Fig.2.4.Anion-exchangechromatography(DEAE-cellulose,pH7.7)fliv rextract. ———Alkalinephosphataseactivity/imolespNPPhydroly d/m n./ )j —Pyrophosphataseactivity/'m lespyropho phatehydroly ed/min./ml.) S28C* nUL 30 Fractionnumber
Fig.2.5.Anion-exchangechromatography(DEAS-c llulose,pH7;7)fi testin- extract.Fractionvolume:15ml.——Alka inephosphataseactivity([■.molespNPPhydroly ed/ in./ml.);P rophosphataseactivity(limolespyrophosphatehydrolys d/min./ml.):—»
280
0.1r-
Fig.2.6. Anion-exchange chromatography (DEAE-cellulose, p!!7.7)
of bone extract. Fraction volume :10.5ml.——— Alkaline
phosphatase activity; (jimoles pNPP hydrolysed. /min./ml.);



























Two substances which differ only slightly in molecular
size may be separated either by gel filtration through a very
long column or by cycling repeatedly them through a shorter
column. The latter method was used after anion-exchange
chromatography in an attempt to separate the phosphatases from
proteins of similar size, which had eluted very close to the
enzyme on the first gel filtration.
Two columns, 55 x 2.5cm. and 90 x 5.0cm. were packed with
oephadex G-200. The concentrated enzyme solution from anion-
exchange chromatography was pumped through the small column;
then the fraction containing the enzyme (identified by the
"^254 mon^-^or trace °n the basis of a trial passage through
the column) was diverted to the base of the larger column.
The enzyme was cycled twice through the large column and the
fractions were collected as before (Figs. 2.7 and 2.8): the
progress of the enzyme through the column being monitored on
a second absorptiometer. If more than two cycles were
attempted the fast fraction overtook the slow fraction.
Considerable dilution occurs during recycling chromatography
and, since the total activity of the bone phosphatase was small,
recycling chromatography was only applied to the liver and
intestinal phosphatases. The increase in the specific activity
with recycling gel filtration was three-fold.
A summary of a typical purification for each tissue is shown
in Table 2.1. At each stage the enzymes were submitted to
Fig.2.7.Recyclinggelf ltration(S phadexG-200-)ofliverxtract. Fractionvolume:10ml.-Alkali ephosphatasectivity(p l pNPFhydrolysed/min./ml.)j—-•S0Qr,
Fig.2,B.Recyclingelfiltratio(SephadexG-200)ofintestinalxtract. Fractionvolume:10ml.———ilkaliphosphataseactivity(pin spMPP hydrolysed/min./ml.);—F„Q.
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starch-gel electrophoresis.
'Table' 2.1. Summary of Purification of Human Alkaline Phosphatases.
Phosphatase activity is expressed as jimoles pNPF hydro-
lysed per min. Specific Activity as )J.moles pNPP hydrolysed
per min. per mg. protein. Results given are for individual
procedures starting with 7*5 kg. liver, 8 kg. small intestine
and 570 g. bone. With bone, after the ammonium sulphate
fractionation 1/5 of the total activity was taken through the
next two stages. Allowance is made for this in the calculation
of yield.
a) Liver:
Total Enzyme Total Specific Overall Purification
Activity "Protean"mg. Activity Yield % Factor
Original 19,700 291,000 0.068 - -
Extract
Acetone 53- 17,200 24,300 0.709 87 10
43/ (v/v)
(NH )pS0. 50- 13,300 10,700 1.24
704 sat.
68 18
Gel Filtration 7,750 535 14.5 39 213
Anion Exchange 3,640 72.5 50.2 18 738
Chromatography





Total Enzyme Total Specific Overall Purification
Activity "Protein"mg;. Activity Yield % Factor
Original 18,000 212,000 0.085
Extract
Acetone 33- 16,500 62,500 0.26 92 3
50/ (v/v)
(NH4)2304 10,4-00 11,820 0.88 58 10
4-0-70/6 sat.
Gel Filtration 6,160 576 10.7 34- 126
Anion Exchange 2,726 84- 32.4- 15 381
Chromatography
Recycling Gel 1,870 21.6 86.7 10.4- 1020
Filtration
c) Bone:
Total Enzyme Total Specific Overall Purification
Activity "Protein"mg, Activity Yield % Factor
Original
Extract 536 4-3,900 0.012
Acetone 33-
507; (v/v) 556 6,070 0.092 100 8
(ni-i4)2so4
25-100/6 sat. 4-00 2,670 0.15 75 12
Gel Filtra- 62 A3 1.4-4 58 120
tion
Anion Exchange
Chromatography 28 3.5 8.0 26 667
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CHAPTER 3. PHYSICAL PROPERTIES OF THE ALKALINE PHOSPHATASES.
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3.1. MOLECULAR WEIGHT.
This was determined by gel-filtration techniques. Andrews
(1965) measured the ratio of elution volume (V0) "to void volume
(V) for a number of proteins of known molecular weight on
columns of Sephadex G-200 under different conditions and
plotted the results as log. (molecular weight) against V /V .0 o
This procedure was used in the present work to determine the
molecular weights of the phosphatases.
The void volume was found by measuring the elution volume
of a substance which is completely excluded from the gel.
"Blue Dextran" 2000 (Pharmacia, Uppsala, Sweden), which has
a molecular weight of about 2 x 10^, was used. Average ratios
of Vg to Vq for the liver and intestinal enzymes respectively
were 1.44- and 1.53. These were reproducible to within 3% when
measured on different columns and with different batches of
Sephadex and correspond to molecular weights of 220,000 and
195,000 respectively (Andrews, 1965). Por the bone phosphatase
an average ratio of 1.54 was found with the same column and
batch of Sephadex. The molecular weight of the bone phosphatase
is, therefore, about 200,000. Although the enzymes eluted as
broad peaks this did not represent a variation in molecular
size, since concentration of the extremes of the peak and a
second filtration on a smaller column gave similar peaks of
enzyme activity with the same elution ratios.
3.2. MOBILITY UNDER STARCH-GEL ELECTROPHORESIS.
The method of starch-gel electrophoresis was based on
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that of Smithies (1955). Perspex trays (10 x 17cm.) were used,
with a removable glass plate at the bottom to facilitate
removal of the gel after electrophoresis. Gel thickness was
about 0.9cm. 150 ml. gel was prepared by the method of Smithies
(1955) using hydrolysed starch (Gonnaught Medical Research Lab.)
in tris-citrate buffer, pH 8.6 (Poulik, 1957). Contact with
the electrode buffer (concentrated boric acid - NaOH buffer,
pH 8.6; Smithies, 1955)1 was via four thicknesses of Whatman
5MM paper. The gel was cooled to 4° and four samples were
applied on pieces of 3MM paper inserted into 1cm. slots about
1-2cm. from one end of the tray. Latterly, larger trays (16-J x
18cm.), which required 300 ml. gel, were used to permit up to
eight samples to be run in parallel. The gels were run
horizontally with the samples towards the end nearer the
cathode. The applied voltage was about 150 volts for the
smaller trays and 250 volts for the larger for 18 hours at 4-°.
A current of 10-20 mA and 30-4-0 mA, respectively developed.
After electrophoresis the gel was sliced horizontally.
Gince there is distortion of the protein zones at the surfaces
of the gel, the alkaline phosphatase activity was located on the
cut surfaces of the gel, using the method of Estborn (1959).
A solution of about 10 mg. sodium <*-naphthyl phosphate in
10 ml. carbonate-bicarbonate buffer, pH 9.9 (Delory and King,
194-5) containing 10 mM Mg01o was poured over the gel surface.
The progress of the reaction in the bands of enzyme activity
in the gel was observed by the appearance of <*-naphthol,
which gave a pale blue fluorescence in ultra-violet light.
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After 5-60 mins., depending on the enzymic activity the gel
was washed with an aqueous solution of tetrazotised o-dianisi-
dine, which couples with the oi-naphthol to give an insoluble
purple complex. Finally the gel was placed in a wash solution
(water: acetic acid: methanol = 5:1:4- v/v) to terminate the
coupling reaction and dehydrate the gel.
A modification of the "direct" method of Allen and Hyncik
(1963) was used to locate the position of enzyme activity
towards inorganic pyrophosphate and orthophosphates whose
organic moieties neither fluoresce nor couple with diazonium
salts. The gel was incubated for up to 60 mins. at 37° in
0.1M tris-HC 1 buffer containing 5^11 substrate and 3®H lead
nitrate; the pH of the buffer was the optimum for the substrate
used. The inorganic phosphate released from the substrate
formed lead phosphate. After washing thoroughly with tap
water for about 1 hour, the lead phosphate was converted to
black lead sulphide by placing the gel in 5$ ammonium sulphide
solution for 1-2 mins. The excess sulphide was removed by
washing with water and the gel placed in a wash solution
(water: acetic acid: methanol = 5:1:4- v/v). This method was
considerably less sensitive than the method of Estborn (1959),
and the black zones representing enzymic activity faded in a
few days even when the gels were stored in the dark.
The results of a typical electrophoresis of the phosphatases
is shown in Fig. 3.1. Liver extracts at the ammonium sulphate
stage of purification showed two bands; in 18 hours the leading
edge of the major band migrated about % of the distance from
Fig.- 3.1. Alkaline phosphatase zones after starch-gel electro¬
phoresis at pH 8.6.(B) Bone preparation at the ammonium sulphate
stage of purification; (L) liver and (I) intestine preparations
after gel-filtration. Anodes are at the top and the sample
insertion slots near the bottom.
B
the point of insertion of the sample to the front, visible as
a yellow line in Poulik's (1957) discontinuous buffer system.
The minor band only migrated a short distance towards the anode.
This less mobile fraction was readily separable from the main
enzyme fraction by gel filtration and electrophoresis of liver
extract beyond this stage only showed the main band.
Bone alkaline phosphatase at the ammonium sulphate stage
of purification also had more than one fraction on starch-gel
electrophoresis. The major fraction was generally a broader .
zone of activity than that of the liver enzyme and the leading
edge of this zone migrated slightly more slowly than the
front of the main liver phosphatase zone (Pig. 3.1*). Again
a minor fraction near the origin was seen when the sample had
not previously been submitted to gel filtration. A third
zone of activity which was less mobile than the major fraction
sometimes occurred instead of the major zone, generally when
the enzyme solution had been stored for some time. This was
considered to be the result of a loss of part of the bone
phosphatase molecule or a change in it which did not affect
the enzymic activity.
The major zone of activity on electrophoresis of the
intestinal phosphatase had a mobility of about 80% of the
mobility of the liver enzyme (Pig. 3*1•)• The minor band
was less intense and had a lower mobility than the corresponding
liver zone.
3.3. ABACTION TO NEURAMINIDASE.
%
0.1 ml. of each phosphatase-containing tissue extract was
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incubated separately with 0.4- ml. neuraminidase solution
(from Clostridium perfringens: Sigma Chemical Co. Ltd., type
V: 1mg./ml. in tris-HCl buffer, pH 7«7) for 24- hours at 37°•
Control tubes containing 0.4- ml. buffer and 0.1 ml. phosphatase
extract were also incubated. Measurement of alkaline
phosphatase activity in the control and in the test tubes after
24- hours showed no loss of activity due to the action of the
neuraminidase. The treated and untreated enzyme solutions
were submitted to starch-gel electrophoresis and the zones of
activity were located as described above.
Both the major zone of the liver enzyme and the minor
fraction near the origin were retarded after neuraminidase
treatment (Big. 3.2.). The mobility of the bone enzyme was
also reduced. The position of the bone phosphatase after
neuraminidase treatment was slightly cathodic to the liver
phosphatase after neuraminidase treatment. On the other
hand, the mobility of almost all of the intestinal enzyme
was unaffected; only a small fraction of the main band
appearing to be sensitive to neuraminidase (Pig. 3*2.b).
Partial purification of the tissue extracts by gel filtra¬
tion did not affect their sensitivity or insensitivity to
neuraminidase. To the neuraminidase solution, which had
been incubated with intestinal enzyme for 24- hours, some
liver extract was added and this was then incubated for a
further 24- hours. Starch-gel electrophoresis showed two zones
of enzyme activity, one in the position of the intestinal enzyme
and the other in the position of the neuraminidase treated
Fig. 3.2. Comparison of alkaline phosphatase zone of liver
and small intestine on starch-gel electrophoresis at pH 8.6,
showing the effect of incubation with neuraminidase,
(a) liver extract; (b) small-intestinal extract. In each
case the sample incubated with neuraminidase is on the
right and the control incubated without neuraminidase on
the left. The sample slots are near the bottom and the




liver enzyme. The lack of effect of neuraminidase on the
intestinal enzyme cannot, therefore, be due to inactivation
of the neuraminidase or to inhibitory factors in the iritestinal
extract.
Incubation with muramidase (iAC. 3.2.1.17.) and hyaluroni-
dase, enzymes which also hydrolyse mucoproteins, produced no
effect on the electrophoretic mobility of the phosphatases.
3.4. -INACTIVATION BY VARIOUS REAGENTS.
3.4.1. Inactivation by heat.
A small quantity of tissue extract in dilute tris-HCl
buffer, pH 7«7« was heated at 5^°-55°. Aliquots were removed
before heating and at intervals throughout the inactivation
procedure and assayed at pH 9.9. The rates of inactivation
may be expressed as the half-life of the enzyme, i.e., the
time taken for the activity of the enzyme to fall to 50% of the
original value. Half-lives of 5, 20 and greater than 90 mins.
were recorded for the bone, liver and intestinal phosphatases
respectively (Fig. 3.3.)• The rate of inactivation is strongly
dependent upon temperature. The half-life for the bone enzyme
varied between 5 and 9 mins. and for the liver enzyme from 20
to 40 mins. in different experiments. An attempt was made to
identify other factors which affected the rates of inactivation.
The addition of 2% albumin, 0.1mM Zn^+ or Mg^+ had no effect
on the stability of the phosphatases.
'when mixtures of two of the isoenzymes were inactivated,
a definite break occurred in the plots of log (% of enzyme
Fig.3.3. Inactivation of intestinal, liver and bone
O
phosphatases during incubation at 55 and pH 7.7.
Substrate: p-nitrophenyl phosphate. O intestinal
phosphatase; o liver phosphatase; A bone phosphatase.
Time (hr.)
-re¬
activity remaining) against time (Fig. 3.4. and 3.5.). The
first part of the curve represents the inactivation of the
thermo-labile bone phosphatase and a small portion of tjie more
thermo-stable liver or intestinal enzymes. The inflection
occurs when all the bone enzyme has been inactivated. These
experiments indicate that the observed differences in
stability are properties of the enzymes themselves, and not
effects due to differences in the composition of their solutions.
3.4.2. Inactivation by urea.
Inactivation of the phosphatases by urea was carried out
in freshly prepared urea solutions in 0.01M tris-HCl buffer,
pH 7.7. The residual activity was determined at pH 9.9 as
before. Urea in the assay mixture causes inhibition of the
enzyme activity. However, the amount of enzyme removed for
assay (generally 20 p.1) was sufficiently diluted in the assay
system (2 ml.) for the effect to be negligible even when the
original urea concentration was high. The rate of inactivation
of the phosphatases is dependent on the urea concentration
(Fig. 3«6.) and on the temperature of inactivation (Fig. 3*7.)•
As with heat inactivation, the enzyme from bone tissue is the
most sensitive to urea and that from the intestine the least
(Fig. 3.8. and Table 3.1.)•
Fig.3*4* Inactivation of mixtures of intestinal and bone phosphatases
during incubation at 54° and pH 7.7. Substrate: p-nitrophenyl phosphate.
O 100$ intestinal phosphatase; 75$ intestinal and 25% bone
phosphatases; o 50%> intestinal and 50$ bone phosphatases;
O 25$ intestinal and 75$ bone phosphatases; A 100$ bone
phosphatase.
Fig.3.5. Inactivation of mixtures of liver and bone phosphatases
during incubation at 55° and pH 7.7. Substrate: p-nitrophenyl phosphate.
O 100$ liver phosphatase; /S. 75$ liver and 25$ bone phosphatases;
o 25$ liver and 75$ bone phosphatases; A 100$ bone phosphatase.
Fig.3.6.Inactivationofb ne(O)ndli r( )alkalinephosphataseifr shlyprepared ureasolutionsat20°CandpH7.7.Ureac centration:( )3m;b5M( )6 .Residual activitywasdeterminedpH9.9.
Fig.3.7.Inactivationofi testinalalkali ephosphatasenfre hlyprep r durea solutionsatpH7.7ndvari ustem eratures.AO0OC;20°j37°c. Residualactivitywasd terminedtpH9.9.
Fig.3.8.Inactivationofli er,bonea dint stinalalkalinephosphatasesfreshlyprepared ureasolutions(6M-)t20°CandpH7.7.QIntestinalphosphataseĵl verphosphatase;Obonephosphatase.Residualctivityw sdeterminedtpH9.9.
- 57 -

















5 20° 11 mins. 9 mins. -






3.4-.3* Inactivation by acid.
The liver and bone phosphatases were inactivated at 0° in
succinate - NaOH buffer, pH 4.4 and in maleate - tris buffer,
pH 3.5. The residual activity was measured at pH 9.9. The
bone enzyme was more sensitive to low pH than the liver enzyme
(Fig. 3.9.). Gcutt and Noss (1968) found the liver phosphatase
to be more readily inactivated by acid than the intestinal
enzyme.
3,5. SUHKAKY OF FINDINGS.
The phosphatases from liver, intestine and bone differed
in their molecular weights and in their mobility under starch-
gel electrophoresis. The alkaline phosphatases from bone and
liver are sensitive to neuraminidase while the intestinal
Fig.3«9.Inactivationofb ne(O)andliverQalkalinephosphatase( )pHU U,0°C
(0.2Msuccinate-NaOHb ff r)nd(b)p3.5,0°C0.0 Mmaleate-trisuff r). Residualactivityr sd te minedtpH9.9.
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enzyme is unaffected by treatment with neuraminadase. The
order of increasing rate of inactivation by urea and by heat




CHAPTER 4. ENZYMIO PROPERTIES OF ALKALINE PHOSPHATASE.
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4.1. SUBSTRATE SPECIFICITY.
Inorganic pyrophosphatase and organic pyrophosphatase
\
activities were found in preparations of alkaline phosphatase
from liver, bone and small intestine at all stages of
purification. Since it has frequently been denied that
alkaline phosphatases have pyrophosphatase activity (e.g.
Norton, 1955) and has instead been contended that any such
activity was to contamination, it was necessary to prove that
the two activities were properties of the same enzyme protein.
4.1.1. Inorganic Pyrophosphate as a Substrate of Alkaline
Phosphatase.
Pyrophosphatase activity was measured as follows. A
small quantity of enzyme solution (20-100pl.) was added to
1ml. buffer-substrate mixture at 37°, containing 3.3mM sodium
pyrophosphate and 1mN magnesium chloride in 0.1N tris-HCl
buffer, pH 8.5 (Cox and Griffin, 1965). After incubation
at 37° the reaction was terminated by the addition of
acetate buffer, pH 4.0, and the liberated inorganic phosphate
measured by the method of Delsal and Nanhouri (1958). The
activity is expressed as pmoles substrate hydrolysed/min./ml.
enzyme solution. Orthophosphatase activity was estimated as
described in Chapter two.
Ratio of Activities: The ratio of orthophosphatase activity
to pyrophosphatase activity for the liver enzyme was 15:1 in
the crude extract, and about 12:1 with the most highly purified
preparations. This variation could be accounted for as the
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effect of metal ions or other non-specific inhibitors present
in the crude extract but removed as the purification proceeded.
The ratio for the intestinal and bone phosphatases remained
constant throughout the purification at 3:1 and about 20:1
respectively.
When the pyrophosphatase activity was measured in the
effluent from the gel filtration and anion-exchange chromato¬
graphy stages of purification, the orthophosphatase and
pyrophosphatase activities had coincident peaks; furthermore,
the ratio of the two activities remained constant across the
peaks for the two enzymatic, activities from each of the three
tissues (Fig. 2.1. - 2.6.). Examination of fractions of the
effluents from anion-exchange chromatography of the liver
enzyme at pH 9.0 (0.01M tris-IICl) also showed coincident peaks
and constant ratios for the two activities (Fig. 4.1. and 4.2.).
Similarly, cation-exchange chromatography of the liver phosphat¬
ase at pH 6.0 (0.01M sodium acetate-NaOH) on GM-cellulose phos¬
phate showed that the two activities could not be separated
(Fig. 4.3.).
Evidence that Orthoohosphatase and Pyrophosphatase Activities
are Properties of the same Enzyme Protein: Mixed substrate
experiments using purified enzyme from each tissues were carred
out. Aliquots of enzyme were incubated separately with 2mM
sodium pyrophosphate and with 2mM pNPP, and, in a third
experiment with both 2mH pyrophosphate and 2mM pNPP simultan¬
eously. The concentration of magnesium ions was 1mM and the
buffer was 0.1M tris-HCl, pll 8.3, in each incubation. The
inorganic phosphate liberated was estimated by the method of
An5.on-exchangechromato raphy(DSAE-cellulo.se,pH9.0)fliv rextr ct,
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Delsal and Manhouri (1958) in all incubation mixtures and,
where pNPP was included, p-nitrophenol was also measured.
For each enzyme the velocity of the hydrolytic reaction* in
the presence of both substrates together was less than the
sum of the two individual velocities, showing that pyrophosphate
and pNPP were not being independently hydrolysed (Table 4.1.).
The pyrophosphatase activity was inhibited more than the
orthophosphatase activity for the phosphatases from all three
tissues.
Liver, bone and intestinal phosphatase were submitted to
electrophoresis on starch-gel at pH 8.6. After electro¬
phoresis the gel was cut horizontally; on one of the cut
surfaces the orthophosphatase activity was developed with
<X -naphthyl phosphate and on the other surface pyrophosphat¬
ase activity was visualised using the direct method of Allen
and Hyncik (1965), using inorganic pyrophosphate as the
substrate in pH 8.5 buffer. The positions of the zones of
the two activities were identical on the two halves of the
same gel, both for the main zone of activity and for the minor
zone near the origin.
In a second experiment samples of liver and intestinal
phosphatase were treated with neuraminidase prior to electro¬
phoresis. When starch-gel electrophoresis was carried out
following neuraminidase treatment the orthophosphatase and
pyrophosphatase activities of the liver enzyme were found to
have been reduced equally in mobility, whereas the mobilities
of the intestinal enzyme bands were unaffected (Fig. 4.4-.).
Fig. 4.4. Sketch of a photograph showing the positions of the
alkaline phosphatase zones in a liver preparation after starch-
gel electrophoresis at pH 8.6. (b) and (c) have been treated
with neuraminidase prior to electrophoresis. Substrates:
(a) and (b) inorganic pyrophosphate; (c) and (d) x -naphthyl
phosphate. Anodes are at the top and the sample insertion
slots at the bottom.
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Table 4.1. Mixed-substrate Experiments with pNPP and Sodium
Pyrophosphate,
Hydrolysis by purified phosphatase preparation of pNPP, sodium
\
pyrophosphate and a mixture of the two at 37° and pH 8.5»
Magnesium concentration 1mM throughout. Enzyme activities



















































Heat inactivation of the liver and intestinal enzymes was
carried out at 55° and pH 7.7 (0.01M tris-HCl). The ortho-
phosphatase and pyrophosphatase activities were determined at
the start and at 5 or 10 minute intervals up to 4-5 mins.
The liver enzyme was inactivated more rapidly than the intest¬
inal phosphatase, but the ratio of orthophosphatase to pyro¬
phosphatase activity remained constant following varying
periods of heat inactivation for both enzymes (Fig. 4-.5.).
In certain types of liver and biliary disease (e.g.
infective hepatitis, obstructive Jaundice, cirrhosis of the
liver) and bone disease (e.g. Paget's disease, hyperparathyro¬
idism) the serum alkaline phosphatase level frequently rises.
Seventy-two human sera with alkaline phosphatase levels ranging
from normal (3-13 King-Armstrong units: Varley, 1962) to
about ten times the upper normal value were assayed for ortho¬
phosphatase and pyrophosphatase activity. The orthophosphatase
activity was measured using pNPP as the substrate at pH 10.0
with suitable enzyme blanks to compensate for Jaundiced sera,
and the pyrophosphatase activity was determined at pH 8.5 hy
a modification of the method previously described in which the
enzymic reaction was terminated by the addition of trichloro¬
acetic acid and the liberated phosphate estimated in the super¬
natant. The alkaline phosphatase in each serum was classified
as originating from liver or from bone tissue on the basis of
other biochemical evidence and clinical data.
The orthophosphatase activity was plotted against the
pyrophosphatase activity for each serum and the regression
lines were calculated (Pig. 4-.6.). The equation for the
rig./,.5.Effectofincubation55%ndpH7 7(tris- Cluffer)n alkalinephosphatasedinorg nicyropho phataseactivitiesf purifiedliveranintestinalzymes.ALive-alk inephosoh"to Aliverpyrophosphatase;Oint tinalalk linep o phatase;
A
A
Ilkalineorthophosplr:t seandin rganicpyro hosphatect vitiesibloodserafrom
patientsv thhep-to ili-ary(O)andb e(Q)disea-es..ctivities"rexpr ss d-moles ofsuostratehydroly.ed/min./l.ferum.Thebrok nlinindicatespperit01normal 100.,,,200,....304- Alkalineorthophosphntasectivity
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regression lines of inorganic pyrophosphatase on orthophos-
phatase (a) is y = 1.174 + 0.055x and of orthophosphatase on
pyrophosphatase (b) is y = 0.354 + 0.060x. There is qtrong
positive correlation between the levels of the two activities
with a correlation coefficient of 0.96. The average ratio
of orthophosphatase to pyrophosphatase activity is 15«7 to 1
and is, therefore, similar to that found for purified liver
and bone phosphatases. No significant difference between
the sera containing alkaline phosphatase which presumably
originated from the liver, and those in which it appeared to
arise from bone, could be seen.
4.1.2. Organic pyrophosphates as substrates of alkaline
phosphatase.
Nucleoside phosphates were used to test the specificity
of the phosphatases towards organic pyrophosphates. The
derivatives of one pyrimidine base, uracil, and one purine
base, adenine, were tried. Thiamine pyrophosphate (TPP),
although not a nucleotide, is a compound of great physiological
importance and it was also tested. In each case the mono¬
phosphates (AMP and UMP) as well as the di- and tri-phosphate
esters were included for comparison, although it is well known
that alkaline phosphatase will hydrolyse AMP (Morton, 1955)*
Relative Rates of Hydrolysis: The relative rates of release
of inorganic pyrophosphate from each substrate by the three
phosphatases were measured at the pH optimum for that substrate,
using 2mM concentrations of substrate both in the presence
(lOmM) and absence of magnesium ions. Since the rate of
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spontaneous hydrolysis of the di- and tri-phosphates is
relatively high, each was examined by paper chromatography
in an ethanol-ammonium acetate system (Smith, 1960a) and all
were found to be chromatographically homogeneous. Each
enzyme preparation had been previously dialysed against
dilute tris-HGl buffer, pH 7«7* to remove magnesium ions.
The relative rates of release of inorganic phosphate are
«
given as a percentage of the activity of the enzyme towards
pNPP, the reference substrate, in the presence of magnesium
(Table 4.2.). The liver and bone phosphatases, unlike the
intestinal enzyme, hydrolyse the monophosphates (AMP and UMP)
more rapidly than the corresponding pyrophosphates (ADP etc.)
in the absence of added magnesium ions. Under similar
conditions the order of decreasing rates of hydrolysis for the
intestinal enzyme is the diphosphate, the triphosphate and then
the monophosphate for each nucleoside. If magnesium ions are
added to a concentration of 10mM in the assay system, then the
monophosphate is the ester most readily hydrolysed with each
enzyme. The different effect of magnesium ions on the hydro¬
lysis of the various phosphate esters will be considered
further when the effects of other metal ions are being
discussed.
Evidence that Orthophosuhatase and Pyrophosphatase Activities
are Properties of the same Enzyme Protein: Mixed-substrate
experiments involving organic pyrophosphatases and orthophos-
phates were carried out in carbonate-bicarbonate buffer as
described previously (page 61). The pH of measurement was
the pH that had been found to be optimal for each substrate
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Table 4.2. Relative Rates of Release of Inorganic Pyrophosphate
from Different Substrates by the Purified .Enzyme
with and without the Addition of 10mM Magnesium ions.
All rates are given as a percentage of the rate of hydro¬
lysis of pNPP at pH 9.9 and in the presence of 10mM magnesium.
Substrate concentration:
several determinations.










































when using 2mM substrate concentrations, and for the adenine and
uracil derivatives and TPP these were in the range pH 9»0 to
9.55 but in these mixed-substrate experiments the concentrations
of each substrate was 1mM throughout. Magnesium ions were
omitted from the assay system since the effect of magnesium
and the optimum magnesium ion concentration is strongly dependent
on the nature of the substrate. The inorganic phosphate
liberated was measured by the method of Baginski et al (1967).
Table 4.3. shows the results of mixed substrate experiments
with each of the adenine and uracil derivatives and pNPP or
AMP, for both the liver and intestinal phosphatases. In each
case the velocity of the hydrolysis of the two substrates
together was less than the sum of the two separate reactions.
Liver and intestinal phosphatases were submitted to starch-
gel electrophoresis at pH 8.6, and the zones of activity
demonstrated using a number of different nucleotides as sub¬
strates. The pattern of the zones of activity on the gel was
identical whichever nucleotides were used as substrate in the
development of the phosphatase bands (Fig. 4.7.)*
Fig. 4.7. Alkaline phosphatase zones in liver (L) and small
intestinal (I) preparations after starch-gel electrophoresis
at pH 8.6. Substrates: (a) oC -naphthyl orthophosphate;
(b) ADP; (c) UTP. Anodes are at the top, sample insertion
slots at the bottom.
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Table 4.3. Mixed-substrate Experiments with Organic Pyrophos¬
phates and. Orthophosphates.
Hydrolysis by purified phosphatase preparations of mixtures
of pairs of substrates at 37° and pH 9.3.
The concentration of each substrate was 1mM and results




























































The liver and intestinal phosphatases were inactivated
by incubating at 54° and pH 7.7 for various times as described
in Chapter three, and the residual activity assayed at pH 9.9.
The activity towards each of the substrates declined in
parallel. 'The marked difference between the rate of inactiv-
ation of the liver and intestinal enzymes was seen with all
the nucleotides (Fig. 4.8.). During inactivation of the
liver enzyme (in JVi urea) and of the intestinal enzyme (in
6M urea) in pH 7.7 buffer at room temperature, similar parallel
losses of activity with all the substrates were seen with both
liver and intestinal phosphatase (Fig. 4.9.). The decline in
activity towards UliP with the intestinal enzyme may, however,
differ from that for the other substrates. The difference in
stability towards urea between the two isoenzymes is again
independent of substrate.
Node of Hydrolysis: Alkaline phosphatase might hydrolyse the
di- and tri-phosphate nucleosides either by removal of each
phosphate group consecutively as orthophosphate, or by removal
of pyrophosphate and its subsequent cleavage to inorganic
phosphate, and an attempt was made to identify the inter¬
mediates in the hydrolysis reaction. Liver and intestinal
phosphatase were incubated for 2-5 hours at 37° with ADP, ATP,
IIDP and UTP separately in buffer at the optimum pH for each
substrate. Since there is considerable spontaneous hydro¬
lysis of the triphosphates, controls without enzyme were also
incubated. The incubation mixtures were run on chromatograms
overnight in an ethanol-ammonium acetate system (0.3N ammonium
Fig.4.8.Inactivationof( )liverandbn esti alphosphatasesdu ing incubationat51?.S strates:AAMP;□D ;VT ;UMP;D VUTP;Op-nitrophenylph sphate.
Fig.A.9.a. Inactivation of liver phosphatase with 3M-urea
O A
during incubation at 20 and pH 7.7. Substrates: AMP;
O ADP; V ATP; Q pNPP.
Time (hr.)
Fig.4.9.b. Inactivation of intestinal phosphatase with 6M-urea
during incubation at 20 and pH 7.7. Substrates: A UKP;
□ UDP; V UTPj QP®'
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acetate, JmM ADTA in 63% ethanol; Smith, 1960a). After
drying the chromatograms the nucleotides were detected as dark
spots under ultra-violet light. The separation between the
di- and tri-phosphates in this system was small and ATP tended
to break down into ADP spontaneously. It was not, therefore,
possible to ascertain- whether or not the diphosphates were
intermediates in the hydrolysis of the triphosphates. however
the monophosphates, AMP and UMP, were produced during the
hydrolysis of ADP and ATP and of UDP and UTP, respectively,
v/ith both the liver and the intestinal enzymes. Similar
experiments with the bone enzyme were not carried out.
A. 1.3. Other substrates.
None of the phosphatases hydrolysed bis (p-nitrophenyl)
phosphate, diphenyl phosphate or NAD.
A.2. TEA AFFECT OP METAL IONS.
A.2.1. The Affect of Magnesium.
The effect of magnesium ions on the action of the phospha¬
tases varies with the type of substrate, the substrate concentra¬
tion, and with the tissue source of the phosphatase. The
effect on the hydrolysis of orthophosphates (e.g. pNPP) at pH
9.9 is to produce a pronounced increase in the rate of the
reaction with even a small increase in the magnesium concentra¬
tion. For instance, with a final concentration of 0.5mM Mg^+
in the assay mixture, and a substrate concentration of 1mM, the
activity of the bone phosphatase is increased about three-fold;
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increasing the concentration further produces a gradual
increase in activity which levels off at about 4-10 mM Mg .
This effect is seen with all three phosphatases, but the over¬
all increase in reaction rate appears to be greater with the
liver and bone enzymes (Fig. 4.10.); this difference may be
due to differences in the residual metal-ion content of the
three preparations. Table 4.4. shows that changes in substrate
concentration in the range 0.2 to 5^ have little effect on
the stimulation of activity by magnesium.
Table 4.4. The Effect of Magnesium on the Hydrolysis of pNPP.
Relative rates of hydrolysis of pNPP at pH 9.9- at
different substrate concentrations with and without the addition
of 10mM Mg2+.
Rates are expressed as a percentage of the rate of hydro¬
lysis in the presence of 10mli Mg2+.
Lnzyme
0.2mM pNPP 5mM pNPP
-Mg2+ +Ng2+ -Mg2+ +Mg2+
Bone phosphatase 15 100 21 100
Liver phosphatase 21 100 17 100
Intestinal
phosphatase
47 100 62 100
A different effect is seen with the hydrolysis of pyrophos¬
phates, e.g. inorganic pyrophosphate at pH 8.5, since the effect
of magnesium is in this case strongly dependent on the substrate
Fig. 4..10. Relationship between magnesium ion concentration and
rate of hydrolysis of p-nitrophenyl phosphate by bone (Q )>
liver (ZS) and intestinal ( O) phosphatases at pH 9.9.
Velocity: X50 for bone phosphatase and X5 for liver phosphatase.
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concentration. At low substrate concentrations (1-2mM) the
rate of hydrolysis increases with increasing magnesium concen¬
tration up to about 0.5 Mg^+, but decreases rapidly .if the
magnesium ion concentration exceeds 1mli. At substrate concen¬
trations of 2-4mh the optimum magnesium concentration is 1 -$mFi.
Fig. 4-.11 shows the relationship between magnesium concentration
and the rate of hydrolysis of inorganic pyrophosphate by the
intestinal enzyme. Bone (Fig. 4-.12.) and liver phosphatases
show similar relationships.
When the effect of magnesium on the hydrolysis of the
organic orthophosphates (e.g. AMP) and pyrophosphates (ADP,
UfP, etc.) by purified liver and intestinal phosphatases was
investigated, it was found that the hydrolysis of the mono¬
phosphates (at 2mM substrate concentration and the optimum
pH for each substrate) was stimulated in a similar manner to
the hydrolysis of pNPP. The hydrolysis of the pyrophosphates,
at 2mM substrate concentration, was activated by concentrations
of magnesium ions less than 1mM but inhibited at higher concen¬
trations, particularly with the intestinal enzyme (Fig. 4.13
and 4.14). The effect of Mg^+ on the hydrolysis of ATP by
the bone enzyme was similar to the findings with the liver
enzyme. The difference between the phosphatases may be due to
differences in the amount of residual magnesium ions in the
preparations rather than to differences between the actual
enzymes.
The difference in effect of magnesium ions on the hydro¬
lysis of orthophosphates and pyrophosphates accounts for the
difference in specificity of the enzymes towards these two
Fig.4-.11.RelationshipbetweenMg^+ concentrationdratefhydrolysisfin rg nic pyrophosphatebyintestin lphosphat seaH8.5.Substr tec ncentrations(mM); O'>1.0;Q,52. ;3*0;4» .
Fig.K*12. Relationship between Kg concentration and rate of
hydrolysis of inorganic pyrophosphate by bone phosphatase at
pH 8.5. Substrate concentrations (mM-)* Q ' ^
O, 2.0; A , 3.0; Q , 4.0.
Fig./,.13EffectofMgionsnratefreleaseom( )adeninenucleotides (b)uridinenucleotides(concn.feach2mM)yi t s inalphosph tase.Substr tes: S7>□yADPj»AT >7^^5Q>UTpJOyp-nitro henyl phosphate(hydr lysismeasur dbr lea efp-nitrophenol).
Fig.4.14..EffectofMgonsntherel asefP^from(a)adeninenucleotidesa(b)uridine nucleotides(concn.fea h2mM)byliverphosp atase.Substr es:̂,A P;[~|D ; ^S,,ATP;\7UMP;GD ;T ;Qp-nitrophenylph sphate(hydr lysismeasured
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groups of substrates seen in the presence and absence of
10mM Mg2+ (Table 4.2.).
4.2.2. The Effect of Zinc.
With all three phosphatases, the presence of I.OjzM Zn2+
in the assay system for the hydrolysis of pNPP (2mM pNPP,
Mg2+ in carbonate-bicarbonate buffer, pH 9.9) caused a slight
activation. However, a further increase in zinc concentration
produced a marked inhibition. The activity in the presence of
100 pM Zn2+ was about 20$ of that in the absence of added zinc
ions. The pyrophosphatase activity (in the presence of 1mM
IIg2+) was also slightly.activated by 1.0 pM Zn2+, but 100 pM
Zn2+ did not cause further inhibition. In the case of the
liver phosphatase, when the same enzyme preparation was used
for the orthophosphatase and for the pyrophosphatase experiments,
a zinc concentration of 1OmM was required to reduce the pyro¬
phosphatase activity to 20$ of its original level.
4.3. KINETICS.
4.3.1. The effect of varying Substrate Concentration.
The effect of substrate concentration on the velocity of
the hydrolysis reaction is dependent on pH and the type of
substrate, and is generally similar for phosphatases from all
tissues. When the effect of varying the substrate concentration
was measured in the absence of added magnesium ions, and at the
pH optimum for hydrolysis with a substrate concentration of 2mM,
the orthophosphates (AMP and UMP) showed an optimum substrate
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concentration at about 4-mIi with only slight inhibition at
8mM. With the pyrophosphates (ADP, UTP, etc.) the optima,
however, were at 2-4 mM with considerable inhibition at" higher
substrate concentrations, particularly with the adenine deriv¬
atives and with thiamine pyrophosphate (Pig. 4.15 and 4.16).
Ross et al (1951) found that the pll optimum varied with
the substrate concentration, when studying the action of rat
intestinal phosphatase on ^-glycerophosphate. This finding
was observed in the present work for the purified enzymes of
human origin, both with orthophosphatase and pyrophosphatase
activities. The plots for the bone enzyme are shown in Pig.
4.17. There is a much greater variation in the optimum pH
with substrate concentration for orthophosphatase than for
pyrophosphatase activity. This has been further demonstrated
by plotting log.(substrate concentration) against optimum pH
in the manner adopted by Ross et al (1951) and by Motzok and
Branion (1959) (Pig. 4.18).
4.3.2. K Values.
m
Tlichaelis constants were calculated from graphs of 1/v
against 1/s, using the adenine and uracil derivatives as
substrates at pH values corresponding to the optimum pH for
2mM substrate concentrations. No magnesium ions were added
(Table 4.5.). Substrate concentrations were in the range 2mI1
to 0.2mli.
Fig.A.15. Relationship between substrate concentration and rate
of release of P. from various substrates for liver phosphatase.
There was no added Mg^+ and measurements were made at the pH
optimum for each substrate at 2mM concentrations. Substrates:
V , AMPj □ , ADP; A , ATP; ^7 , UMP; □ , TJDP, A
Substrate concn. mM
Fig.A.16. Relationship between substrate concentration and rate of
release of P^ from various substates for intestinal phosphatase.
There was no added Mg^ and measurements were made at the pH optimum
for each substrate at 2mM concentration. Substrates: V > AMP;
□ , ADP; A , ATP; V > UMP? □ , UDP; A , UTP.
Fig.4-.17. Dependence of optimum pH for hydrolysis by bone phosphatase
of substrate concentration, (a) with p-nitrophenyl phosphate as
substrate; (b) with inorganic pyrophosphate as substrate. Substrate
concentrations (mM-); 0 ,0.5; O »°*1> LI ,0.05; Q ,0.025; LL ,0.01.
2 ~—
X 10
Fig.4-.18. Relationship between log of substrate concentration
and optimum pH for hydrolysis of inorganic pyrophosphate (0 )
and p-nitrophenol phosphate (Q) by bone alkaline phosphatase
Optimum pH
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Table A.5» K^ Values (mM) for Liver and Intestinal phosphatase.







UTP 0.8 ' 1.0
TPP 6.5 1.2
The values for the bone phosphatase, under similar conditions,
could not be determined precisely, but were estimated to be of
the same order as those for the liver and intestinal enzymes.
The K values at different pH values were determined for
m ^
each phosphatase acting on the substrates pNPP and inorganic
pyrophosphate. Since the effect of magnesium ions is complex
magnesium was not added to the assay mixtures. The buffers
used were tris-HCl (0.1M) over the range pH 7 "to 9.5, ammediol
(2-amino-2methyl-1,3-propandiol)-HCl (0.1M) over the range pH
8.5 to 10.2, and in a few cases the carbonate-bicarbonate
buffers of Delory and King (1945) were used at pH values
greater than 10.0. The orthophosphatase activity at 37° was
measured as the increase in absorption at 4-00 mp in a recording
spectrophotometer. When inorganic pyrophosphate was the
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substrate, the incubation was for a fixed time (usually 5 mins.),
and the liberated phosphate was being measured by the method
of Baginski et al (1967).
values were calculated from graphs of s/v against s;
the velocity was expressed as pinoles substrate hydrolysed/min./
ml. The use of different buffers was not found to have any
effect on the values. When pKffl was plotted against pH
(Dixon, 1953a) a series of curves with straight portions of
gradient 0,-1 or -2 fitted the experimental points quite well.
An extension of the lines gave pK values for the various
ionisations affecting the enzyme-substrate interaction. Pig.
4-.19 shows the "Dixon plots" for the orthophosphatase activity
for the three phosphatases. The results for the three enzymes
are similar for their orthophosphatase activity, each having
an ionisation between pH 8.5 and pH 8.8. This type of
inflexion can represent either a pK or a pK^ but, since pNPP0 S
does not have a pK in this region, it is presumably the pK of
a substrate-binding group in the enzyme molecule. The graph
for liver phosphatase may have a second inflexion about pH
10.2, representing a pK of the enzyme-substrate complex
(pK ). The bone and intestinal enzymes do not indicate a0 s
pK around pH 10.5, But the Km values were not determined0 S
above this pH since the enzyme activity is very low at high
pH values. The overall change in for the orthophosphatase
activity varied by 4-0 to 70 times over the range from pH 8.5
to pn 10.5.
Fig. 4-.20 shows the "Dixon plots" for the inorganic pyro-
Fig.4-.19. Plots of pK (-log K (mM-)) against pH for the action ofin in
(a) liver, (b) bone and (c) intestinal phosphatases of p-nitrophenyl
phosphate. Buffer solutions: £) , tris-HGlj ^ , amraediol-HCl;
£3 , carbonate-bicarbonate.
Fig.4.19. (c)
Fig.4-.20. Plots of (-log Kq (mM) ) against pH for the
hydrolysis of inorganic pyrophosphate by (a) liver, (b) bone


























phosphatase activity. Since the pH optimum of the activity,
with a substrate concentration of 1mM, is in the region of pH
8-9, the values were measured over the range pH 7-9.5.
The variation in with pH between pH 7.5 - 9.5 with this
substrate is about five fold over a range of two units of pH.
Two or three inflexions were seen in each case with inorganic
pyrophosphate. Table 4.6 indicates the pH values at which
these occurred.









from -2 to 0 - - 7.4
from 0 to -1 7.5 Co • 8.4
from -1 to 0 8.1 8.55 8.95
There is greater variation in the pK values where the gradient
changes from 0 to 1, with this substrate. The pK values for
the ionisation of three of the hydroxyl groups of inorganic
pyrophosphate lie below 6.0; however, the fourth hydroxyl
group has been reported to have a pK for its ionisation between
8.2 and 9.4 in the literature, and a pK of 9.1 for this ionis¬
ation was found by titration, at ionic strength 0.01, in the
present work. Thus, the pK values at 7.5 8.1 and 8.4 must
represent pK values, and not values for pK , for .the three© s
phosphatases. The dissimilarity between the three phosphat-
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ases is also seen in the pKes values, which vary between 8.1
and 8.95* The second concave bend found in the curve for
the intestinal enzyme, at pH 7.5? may represent a second pK ;* © s
since this slope has a gradient of -2, it would represent the
simultaneous ionisation of two groups.
At pH 7.0 the affinities of the enzymes for the two
classes of substrate are relatively unaffected by the type of
substrate and by the tissue source of the enzyme (Table 4.7.)•
On the other hand, at pH 9.0 the liver and intestinal enzymes
show a greater affinity for orthophosphate than for pyrophos¬
phate, the difference in affinity being 5-10 fold. Increasing
the pH to 10.5 produced a marked increase in the K for ortho-
phosphate with all three phosphatases.
Table 4.7. A Comparison of the Values (mil) for the Hydro¬
lysis of pNPP and of Inorganic Pyrophosphate (PIA )
at Different pH Values.
Lnzyme
Source
pH 7.0 pH 9. 0 pH 10.5
pNPP PP.l pNPP PP.l pNPP
Liver 0.02 0.04 0.06 0.2 0.8
Bone 0.01 v~O•c 0.02 0.05 0.6
Intestine 0.01 0.01 0.025 0.2 0.7
V at each pH was calculated from graphs of s/v against
max * f ' t>
s for orthophosphatase activity, using pNPP as substrate and
log V was then plotted against pH (Pig. 4.21). Thesemax
latter graphs should, in theory, consist of a series of lines
Fig.U.21. Variation of log V with pH for the hydrolysis ofIH3.X
p-nitrophenyl phosphate by liver(a), bone(b) and intestinal(c)















of zero and of unit slope joined by curved portions, the
intersections of the straight portions giving pK values for
the enzyme-substrate complex. However, such lines do not fit
the experimental points well. A discontinuity about pH 10.0
could be postulated for the liver enzyme, which would correspond
to the pK found in the pK plots.r es ^ m ^
Lines of unit and zero slope could be more readily fitted
in the graphs of log V against pH for the inorganic pyrophos-max
phatase activity (Fig. 4.22), and pK values of 7.9 (liver0 S
enzyme), 9.1 (bone enzyme) and 7.9 (intestinal enzyme) were found.
It is probable that there is a second pK value for the liver0 s
enzyme above pH 9.0, and- for the bone enzyme below pH 8.0; in
each case the start of the curve can be seen. Similarly a
second pKQs above pH 10.0 might be shown by the intestinal
enzyme if it were possible to extend observations sufficiently
above pH 9.0.
At pH 7.0 the orthophosphatase and the pyrophosphatase
activities of the bone enzyme have similar V values, where-max
as at pH 9.0 the pNPP activity is three to four times greater
(Table 4.8.). The ratio of V for pNPP at pH 10.5 to Vmax max
for pyrophosphate at pH 8.5 is about 15 to 1, which resembles
the ratio of the two activities when each is measured under
optimum conditions of pH and magnesium concentration. The
increase in V with increasing pH, using pNPP as substrateIllciX
reflects the high pH optimum of the enzyme with that substrate.
Fig.A.22. Variation in log with pH for the hydrolysis of
inorganic pyrophosphate by liver(a), bone(b) and intestinal(c)
phosphatases. Buffer solutions: Q > tris-HClj , ammediol-HCl
pH
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Table 4.8 A Comoarison of the V Values for Orthoohos-
max
phatase (pNPP) and Pyrophosphatase (PP^) Activity
for the Bone Enzyme at Several pH Values.






Note: Corresponding tables for the V_ values with liver andr ° max
intestinal phosphatases could not be produced from the results
of the velocity determinations, since different enzyme prepar¬
ations were used for the orthophosphatase and pyrophosphatase
assays.
4.4. INHIBITION.
The inhibition of orthophosphatase activity by inorganic
pyrophosphate was measured at pH 8.9 (0.1M tris-HCl) with pNPP
as substrate. Magnesium ions were omitted. The results
were plotted as 1/v against the concentration of inhibitor
(Dixon, 1953b), and it was found that inhibition was competitive
(Fig. 4.25.). At pH 8.9 the rate of hydrolysis of pyrophos¬
phate is fairly low, while the orthophosphatase activity is
still readily measured. In a similar experiment the inhibition
of inorganic pyrophosphatase activity by pNPP was measured at
Fig.4..23. Plot of l/v against i for inhibition of
orthophosphatase activity of intestinal phosphatase by
inorganic pyrophosphate at pH 8.9. Substrate (p-nitrophenyl
phosphate-)' concentrations (mM): O J0-1* A >0.255 □ >0.5.
Initial velocity,v, is expressed as [xraoles/min./ml.
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pH 8.5. The rate of breakdown of pNPP at pH 8.5 in the absence
of magnesium ions is low and the incubation time was kept short.
The inhibition was again found to be competitive (Pig. ,4.24.).
The inhibition by inorganic pyrophosphate of pNPP activity
of the bone and liver enzymes at pH 8.9 was also competitive.
The corresponding inhibition by pNPP was not studied.
The relationship between pyrophosphate inhibition of
orthophosphatase activity and magnesium concentration was
studied using o(. -naphthyl phosphate as substrate. The velocity
of hydrolysis was observed in a recording spectrophotometer
by measuring the increase in absorption at 335mp due to the
production of oc-naphthol (Hoss, 1966), in the presence of
the carbonate-bicarbonate buffer, pH 9.9- The results for
the inhibition of the orthophosphatase activity of intestinal
phosphatase by inorganic pyrophosphate at different concentrations
of inhibitor and varying concentrations of magnesium ions are
plotted in Fig. 4.25. Tn the absence of inhibitor the optimum
concentration of iig^+ was 1mh but, as the concentration of
pyrophosphate was increased, there was an upward shift in the
optimum concentration of magnesium (Fig. 4.25b). This could
be due to the formation of a complex between magnesium ions and
pyrophosphate ions, with a consequent reduction in the effective
magnesium concentration.
Fig. 4.25a shows that, in the absence of added magnesium,
orbhophosphatase activity was slightly inhibited by pyrophosphate,
but that pyrophosphate acts as an activator with 6.7hT1 hg2+.
This is thought to be due to the removal by inorganic pyrophos-
Fig.lv,2U*Plotof1/vagainstf rinhibi ionfpyroph sphataseactivityfin es inal phosphatasebyp-nitroph nylosphateH8.5.Sub trate(i rg nicphosphate)c n ns (mM):Q),1.0;/S,2.0;,3. .Initialvelocity,,isxpresseda|imo es/min./ml.
Fig.4-.25. (a) Relationship between orthop'nosphatase activity (substrate,
3.3mM c-naphthyl phosphate) and inorganic pyrophosphate concn, at
pH 9.9. Mg2+ concns.(mM): Q ,0; □ ,1.0; A ,3.3; O ,6.7.
Intestinal enzyme was used, (b) Replotted as v against Mg2+ concn.

































phate of the slight inhibition produced by excess magnesium
ions.
At pH 9.9, with 3«3 mil oi -naphthyl phosphate as substrate
and without the addition of Mg^+, lOrnM inorganic pyrophosphate
inhibited the orthophosphatase activity by about 10?y (Fig.
A.25). On the other hand, at .pH 8.9 and in the presence of
1.OmFi inorganic pyrophosphate, the inhibition of the ortho¬
phosphatase activity, measured by the hydrolysis of 0.5®M
pNPF, was 4433; these findings are calculated from the results
presented in Fig. 4.23. It would, therefore, appear that
pyrophosphate does not bind so strongly to the phosphatase
at pH 9.9 as at pH 8.9« This is in agreement with the
observation that K increases in value with rise in pH,m ^ '
noted for the intestinal enzyme when using inorganic pyrophos¬
phate as substrate (Table 4.7.).
L-phenylalanine inhibits the alkaline phosphatase from
intestine but is without effect on alkaline phosphatase from
other tissues (Fishman et al, 1982), and these findings have
been confirmed for the enzyme studied in the present investi¬
gation. The activities of purified liver and bone phosphatases
were unaffected by the addition of L-phenylalanine to the assay
system. The inhibition by L-phenylalanine of the orthophosphat¬
ase activity of intestinal phosphatase was measured at pH 9.9
(carbonate-bicarbonate buffer), without the addition of magnesium
ions, using pNPP as substrate. The inhibition of pyrophosphatase
activity at pH 8.5 (0.1M tris-HCl) was also measured. Plots
of 1/v against the concentration of inhibitor showed that
the inhibition was non-competitive in type for both activities
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(Fig. 4.26), and the inhibitor constants (Kh) were calculated
(Table 4.9). When the inhibition of the two activities was
measured at the same pH (0.1M tris-HCl, pH 8.9) the inhibitor
constants were the same foj* both substrates (Fig. 4.27).
At pH 8.9, low concentrations of pNPP must be used because a
shift in the optimum pH to low values occurs with decreasing
substrate concentration leads to inhibition by excess substrate
as noted by Tiotzok (1950) and Ross et al (1951).
Sodium arsenate acted as a competitive inhibitor of the
orthophosphatase and pyrophosphatase activities of all three
alkaline phosphatases studied. K. values were similar forc 1
both activities when they were measured at the same pH (Fig.
4.28-4.31), and the inhibitor constants for each enzyme are
recorded in Table 4.9.
4.5. CATALYlIC-CiFiTRF ACTIVITY.
Barman and Gutfreund (1966) estimated the catalytic-centre
activity of bovine milk alkaline phosphatase by labelling the
active centre of the enzyme with inorganic phosphate labelled
32
with P. In the present studies, purified human liver and
32
intestinal alkaline phosphatases were phosphorylated with P
by a modification of the method of Barman and Gutfreund (1966).
About 1-3 mg. protein, having a total enzyme activity of
approximately 50 pmoles pNPP hydrolysed/min. at 37° , was
incubated with varying amounts of sodium orthophosphate
(0 - 2mII) and a known amount of carrier-freeL^p3 - ortho-
phosphate dissolved in sodium acetate - acetic acid buffer,
pH 5»0 (0.05M and 0.035 ^ with respect to magnesium acetate).
Fig.4..26.Plotsof1/vagainstf rinhibi ionfi test nalrthopho phatasea d pyrophosphatasebyL-phenylalanineaH9.9nd8 5espectiv ly.Substr t concns.(mil):p-n trophenylphos ate:,0.25;A>2-0;py hosphate:C),0. ; A,5.0.Initialvelocity,,isexpressedapmoles/min./ml.
Fig.A.27.Plotsfl/vagainstf rinhibitionntes nalrthophosphatasea d pyrophosphataseactivitiebyL-phenylalaninH8.9.Substr teoncns.(mM): p-nitrophenylphosphate:O>0.02;A, .1o.5inorganicpyro osphate: CA,3.0.Initialvelocity,,isexpressedapinol s/min./ml.
Fig.4.28.Plotsofl/vagain tf rinhibitionfi tes nalrthoph sphatased pyrophosphataseactivitiesbyarsen tpH9.9ndH8.5respectively.O,A □,orthophosphatase;O>Apyr osphat se:Substr tconcn .(mM) Arsenateconcn.(mM)
Fig.4.29.Plotsof1/vagain tf rinhibit onfi testinalorthophosph ta eandpyroph s activitiesbyarsenatpH8.9.O'A'□>orthophosphatase;Q,pyrophospha ase. Substrateconcns.(mM):p-nitrophe ylph te:0> .i;A»o.25;□,0 5;yrophosphaQ, ; /\ ,1.0;l],3.0.Initialvelocity,isexpressedanmol /min./ml.
Fig.4.30. Plots of 1/v against i for inhibition of liver orthophosphatase
and pyrophosphatase activities by arsenate at pH 8.9. Substrate concns.(mM):
p-nitrophenyl phosphate: , 0.1; ^ , 0.25; O > 0.5; pyrophosphate:




Fig.4.31. Plots of l/v against i for inhibition of bone orthophosphatase
and pyrophosphatase activities by arsenate at pH 3.9. Substrate concns.
(®M): p-nitrophenyl phosphate: Q , 0.125; , 0.25; Q , 0.5:
pyrophosphate: Q , 0.3; , 1.5. Initial velocity, v, is expressed
as pmoles/rain./ml.
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Table 4.9. Values of EL (mM) for the Inhibition of Orthophos-
phatase and Pyrophosphatase Activities of Purified
Intestinal, Liver and Bone Preparations.
Enzyme Substrate Inhibitor pH Ki Type ofinhibition
Intestinal
phosphatase Pyrophosphate pNPP 8.5 0.09 competitive
pNPP Pyrophosphate 8.9 0.05 competitive
Pyrophosphate L-phenylalanine 8.5 0.5 non¬
competitive
Pyrophosphate L-phenylalanine 8.9 0.8 non¬
competitive
pNPP L-phenylalanine 8.9 0.8 non¬
competitive
pNPP L-phenylalanine 9.9 5.5 non¬
competitive
Pyrophosphate Arsenate 8.5 0.025 competitive
Pyrophosphate Arsenate 8.9 0.02 competitive
pNPP Arsenate 8.9 0.02 competitive
pNPP Arsenate 9.9 0.25 competitive
Liver
phosphatase Pyrophosphate Arsenate 8.5 0.02 competitive
Pyropho sphate Arsenate 8.9 0.02 competitive
pfiPP Arsenate 8.9 0.02 competitive
pNPP Arsenate 9.9 0.4 competitive
Bone
phosphatase Pyrophosphate Arsenate 8.9 0.02 competitive
pNPP Arsenate 8.9 0.02 competitive
pNPP Arsenate 9.9 0.58 competitive
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This solution (total volume: 1.0ml.) was kept at 0° for 3 mins.
and then X-globulin (img. in 0.1ml. water) followed immediately
by 0.2ml. of 20%' (v/v) perchloric acid were added. The
Y -globulin was added to assist in the precipitation of the
enzyme. Control tubes for each phosphate concentration were
incubated similarly except that an amount of -globulin
equivalent to the enzyme protein was added instead of the enzyme.
The precipitates were washed five times with a total volume
of 30ml. 5% (v/v) perchloric acid and were then dissolved in
0.5ml. 90/ formic acid. The total radioactivity in the
solution was measured by liquid scintillation counting (Packard,
Tricarb). The liquid scintillator contained 6 gm. diphenylox-
azole, 0.3 gm. 1/4- bis-5(-phenyl oxazol-2-yl) -benzene, and
100 gm. naphthalene in 1 litre dioxan. Considerable quenching
was observed during counting but a correction was applied by
32
the addition of internal standards of P.
For a simple dissociation of phosphorj'l enzyme into free
enzyme and orthophosphate, the equation CP ^ s E + P can be
written.
Then, K = [e LP \ where K is the dissociation
constant.
If EP = the concentration of phosphoryl enzyme
Pq = the total orthophosphate concentration
EQ » the total enzyme concentration
then [E] = EQ - EP and [P] = PQ - EP.
Since EP is very small compared with P , P is approximately
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equal to Po the expression becomes








If is plotted against PQ then a straight line of gradient
1/Eq and with an intercept on the x-axis equal to -K is obtained
Eo represents the concentration of sites on the enzyme which
bind phosphate at pH 5-0. If it is assumed that this is the
concentration of catalytic-centres in the molecxile, and that
they are all equally labelled, then the catalytic-centre
activity of the enzyme can be calculated.
the results for the liver and intestinal phosphatases
were plotted in this manner, and the results are shown in
Table 4.10 and Fig. 4.32. From the graphs the concentrations
of active sites were found to be 0.18 pi! and 0.14 juM for the
liver and intestinal phosphatases respectively, and the
catalytic-centre activities were calculated to be 5030 sec.
and 6550 sec.-^ for pNPP at 37° and pH 10.0. The dissociation
constant for the phosphorylated enzyme from intestine is 2 x
-4
10 Vl, but the value for the liver enzyme is too low to be
measured with accuracy. To make sure that bh© uptake of
32v P was due to incorporation into active enzyme and not the
32
result of non-specific absorption, labelling with P was
carred out with a set of controls containing heat-inactivated
enzyme, and with another set in the presence of a high
Fig.4-.32. Plot ofP^EP against Pq where Pq is the total
orthophosphate concentration andEP the concentration
of catalytic centres combined with phosphate.'
O liver phosphatase; O intestinal
phosphatase.
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concentration of a substrate (20mM pNPP); the uptake of
radioactivity was reduced in both instances.
.Estimation of the purity of the enzyme preparations: If the
molecular weights of the liver and intestinal phosphatases are
taken as 220,000 and 195,000 respectively (Chapter three), the
purity of the best preparations can be calculated. For the
liver enzyme the average specific activity obtained at the
final stage of purification was 14-8 pmoles pNPP hydrolysed/
min./mg. protein (Chapter two). Assuming one catalytic-
centre/enzyme molecule, the specific activity of the pure
enzyme would be 1370 pmoles pNPP hydrolysed/min./mg. protein;
the purity of this preparation is thus about 11$. Similarly,
the highest specific activity found for the intestinal enzyme
was 130 pinoles pNPP hydrolysed/min./mg., which corresponds to
a purity of 7/«
If the molecular weights of the human alkaline phosphatases
are compared with the value for the E.coli phosphatase, which
has a molecular weight of about 80,000 (Garen and Levinthal,
1960), and account is taken of the fact that E.coli phosphatase
consists of two subunits (Schlesinger and Barrett, 1965) this
would suggest that alkaline phosphatase in human tissues is
composed of four subunits. If this is the case and each
subunit has a catalytic centre, then the purities of the best
preparations studied in the present experiments would be only
about 3/-' for the liver and 2/ for the intestinal phosphatases.
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Table 4.10 Incorporation of ^P by Liver and Intestinal
Phosphatases at pH 5.0«
Expt. A: Liver phosphatase, enzyme activity 54-.4 pinoles pNPP
hydrolvsed/min., protein content 2mg. Initial
radioactivity 2.994- x 10^ cts./min.*
Expt. B: Intestinal phosphatase, enzyme activity 55.4 pinoles
pNPP hydrolysed/min. , protein content 2.7 nig.
n
Initial radioactivity 2.548 x 10 cts./min.

















































The bone phosphatase was not obtained in sufficient quantity
and purity to permit the catalytic-centre activity to be
estimated.
4.6. SUMMARY OF FINDINGS.
The alkaline phosphatases from liver, intestine and bone
all hydrolyse inorganic pyrophosphate and several organic pyro¬
phosphates (e.g. ADP, UTP, TPP, etc.) but do not hydrolyse
phosphate diesters. In each case the pyrophosphatase and
orthophosphatases activities are properties of the same enzyme
molecule. The ratio of the two activities varies with the
isoenzyme; the intestinal preparation having relatively the
greatest pyrophosphatase activity and liver and bone phosphat¬
ases approximately equal relative activities.
The isoenzymes varied with respect to the effect of metal
ions on the rates of hydrolysis both with orthophosphatase and
pyrophosphatase activities. Kinetics of the hydrolysis
reaction also varied with the tissue source of the alkaline
phosphatase. Arsenate inhibited both the inorganic pyrophos¬
phatase activity and the orthophosphatase activity of all three
isoenzymes competitively. On the other hand phenylalanine
inhibited the intestinal enzyme noncompetitively but had no
effect on the enzymes from bone and liver. A study of the
catalytic centre activities showed liver and intestinal
phosphatases to differ in this respect.
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CHAPTER 5. AN EXAMINATION OF THE MOLECULAR STRUCTURE.
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5.1. INTRODUCTION.
An examination of the amino acid sequence at the active
centre of alkaline phosphatase molecules has been made by
Angstrom (1964b) on calf intestinal phosphatase, and by
Milstein (1964) on £. coli alkaline phosphatase. Angstrom
(1961b) found that, ii> calf intestinal phosphatase was
52incubated with P-orthophosphate and subsequently hydrolysed
with hydrochloric acid at 100°, serine phosphate with a radio-
w
active label could be isolated. The incorporation was maximal
at pH 5-0 and complete in 20 sees; there was no incorporation
with enzyme that had previously been inactivated by heat. By
partial hydrolysis of the enzyme labelled in this way, the amino
acid sequence around the serine residue in the phosphatase
molecule was found to be aspartic acid-serine-alanine for both
the calf intestinal enzyme (Angstrom, 1964b) and the phosphatase
from A. coli (Milstein, 1964).
It therefore appeared probable that there was a serine
residue at the active centre of human alkaline phosphatase and
attempts were made to verify this. It was also hoped to show
whether liver and intestinal alkaline phosphatases differ in
molecular structure in the region of their active centres, by
investigating whether differences existed in the patterns of
labelled peptides prepared from the two enzymes.
5.2. LABALLING OA LIVAR aLKALINA FHOSPHATASA WITH ?2P-PH03PHAT£:
PRALIMINARY AXPARIMANTG.
Liver phosphatase (enzyme activity: 18 yimoles pNPP hydro-
-z p
lysed/min. Total protein: 20mg.) was incubated with 9 P-
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phosphate (about ImCurie) and 10mpmoles orthophosphate in
acetate buffer pH 5*0 (total volume: 1.8ml.). The radio¬
activity of the incubation mixture was measured in a Geiger-
Muller counter. After 5 mins. at 0°, 0.3ml. 3N HC1 was added
and the precipitate removed by centrifugation. The radio¬
activity in the supernatant was measured in a Geiger-Muller
counter and the supernatant discarded. The precipitate was
washed twice with acetone - HC1 (8 vol. acetone and 2 vol.
0.5N HGl) and, after drying overnight in vacuo over KOH, was
dissolved in 1ml. 0.01N HGl and its radioactivity measured.
The results of a typical labelling experiment are given in
Table 5.1.
32
The solution containing the protein labelled with P,
was divided into two fractions. One of these was hydrolysed
with 8 mg. pepsin at 37° and pH 2.0 for 24 hours and the other
by UN HGl for 3? days at 37°.
7)2
Table 5.1. Labelling of Liver Phosphatase with ^ P-Phosphate.
Sample counted Total cts./sec. % original
Original incubation mixture 4 x 106 100
Supernatant after precipitation
of labelled enzyme
3 x 106 75
Pirst washing 7.6 x 105 19
Second washing 1.2 x 10^ 0.3
High voltage electrophoresis of the mixture of peptides
was carried out as follows. A piece of Whatman 3MM filter
paper, approximately 41 by 38cm., was soaked in buffer and
- 94 -
excess buffer removed by pressing between sheets of filter
paper. The sample was then applied as a one inch streak
about 10 cm. from one end, and the paper placed on the'pre-
cooled plate of a "Mini Pherograph" (L. Hormuth, Heidelberg).
The electrical contact was via platinum block-electrodes
pressing on to filter paper strips previously soaked in buffer,
the anode being at the end further from the sample. A
voltage of 1500 volts was applied for 1 to 1-J hours. After
v
electrophoresis the paper was removed, dried and the strip
containing the sample cut out and scanned for radioactivity
on an automatic scanner (Nuclear-Chicago) or used for auto¬
radiography. Unlabelled inorganic phosphate was run in
parallel with the sample, and was located by dipping the strip
containing the phosphate into a freshly prepared molybdate
solution consisting of 8 vol. 12-J/ (w/v) ammonium molybdate,
3 vol. 11N HC1, 3 vol. 12N perchloric acid and 86 vol. acetone
(Smith, 1960b). The paper was dried and exposed to ultra¬
violet light for at least half an hour, by which time the
phosphate marker appeared as a blue spot.
After pepsin treatment the hydrolysate was submitted to
electrophoresis at pH 6.5 in pyridine-acetic acid buffer
(pyridine: glacial acetic acid; water = 10:1:100, v/v).
The radioactivity scan showed two peaks, one at the origin
and one that had moved towards the anode (Fig. 5*l2i)« With
the other fraction, after acid hydrolysis, electrophoresis
at pH 3.5 (pyridine; glacial acetic acid; water = 1:10:100
v/v) showed one peak at the origin. Chromatography of the
acid-hydrolysed material in butanol-acetic acid (n-butanol:
Fig.5.1.a. Radioactivity scan of electrophoresis '
at pH 6.5 of the peptic hydrolysate of liver
32
phosphatase labelled with P-phosphate.
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acetic acid: water = 120:30:50, v/v) for 18 hours resulted in
a separation of the radioactivity into two peaks, one of which
ran with the same R^ as inorganic phosphate (Fig. 5-1h).
To determine whether hydrolysis of the enzyme was occurring,
a portion of phosphorylated enzyme was incubated with concentrated
hydrochloric acid (37° for 3 days) and was then dialysed over¬
night. Fig. 5*2. shows the result of electrophoresis at pH 3.5
of both the fraction within the dialysis sack and that outside.
v
Since only inorganic phosphate and small peptides can pass
through the sack, some hydrolysis of the protein must have
occurred. Amounts of radioactivity were too small to allow
elution and re-chromatography of the peaks.
5.3. LABELLING OF E.COLI ALKALINE PHOSPHATASE WITH ^2P-PHOSPHATE.
To ensure that the method of labelling and hydrolysis of the
human enzyme was effective, attempts were made to reproduce the
results of Milstein (1964) with E.coli alkaline phosphatase
obtained from Sigma Chemical Co., London. 5 nig. of the enzyme
suspension (enzyme activity: 140p.moles pNPP hydrolysed/min./
ml.) were labelled with radioactive phosphate by the method of
Milstein (1964). Table 5*2. shows the results of the labelling.
Table 5.2. Labelling of E.coli Phosphatase.
Sample counted Total cts./sec. % original
Original incubation mixture 3.8 x 107 100
Supernatant after precipitation
of labelled enzyme
2.9 x 106 8
First washing 1.4 x 105 1




Fig.5.?. Radioactivity scans of the electrophoresis
\
at pH3#5 of ihe acid hydrolysate of the liver
3o
phosphatase labelled with " P-phosphate. The
hydrolysate was dialysed for 18hr. against,
buffer.
a) fraction outside the dialysis sack
b) fraction inside the dialysis sack.
anode cathode
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The labelled enzyme was subjected to digestion with pepsin
after oxidation with perchloric acid. Electrophoresis of the
digest at pH 6.5 gave four peaks of radioactivity (Fig.< 5»3»b).
This tracing closely resembled the results of Milstein (1964)
under similar conditions, except that Milstein was able to
resolve peak three (Fig. 5*3«b) into three separate peaks.
Peak three was eluted in water, evaporated to a small volume,
hydrolysed with HC1 and submitted to electrophoresis at pH 5*5«
Ten bands of radioactivity were visible (Fig. 5«^»)«
autoradiograph showed more clearly the separation between
bands 4, 5 and 6, and between 9 and 10. There was also an
indication of a band cathodic to the origin. In this electro-
pherogram the inorganic phosphate was allowed to run off the
paper. Milstein (1964), with an electropherogram of about
twice the length, had 16 distinct bands, but, the bands of
greatest intensity observed in the present work were similar
to those of Milstein (1964).
Hydrolysis by hydrochloric acid for varying lengths of
time gave a trace consisting of four peaks (Fig. 5«3»a)«
There was no significant difference between traces for different
lengths of time of hydrolysis. Milstein (1964), in a separation
of about twice the length, observed 16 bands of radioactivity
of varying intensity. It would, therefore, appear from the
results of the peptic hydrolysates that the E.coli phosphatase
has been labelled and hydrolysed.
Fig.5.3«a. Trace of radioactivity scans of the electrophoresis at




Fig.5.3.b. Trace of radioactivity scan of the electrophoresis at
3?







5.4. A SECOND ATTEMPT TO LABEL LIVER PHOSPHATASE.
Since a repetition of Mlstein1s (1964) experiment with
\
E.coli phosphatase had been achieved, a second attempt to label
the liver enzyme was made. Phosphatase (enzyme activity: 119
jumoles pNPP hydrolysed/min. ; protein: 3mg.) was incubated
32 /with y P-phosphate as described previously. Less than 1% of
the radioactivity in the incubation mixture was incorporated
into the enzyme protein.
v
A portion of the solution containing the phosphorylated
enzyme was oxidised with performic acid and incubated with
pepsin at pH 2.0. Electrophoresis at pH 6.5 resulted in
tracings consisting of three peaks (Fig. 5»5«a). This
tracing differed from that found when the liver phosphatase
was first labelled with ^ P-phosphate and hydrolysed with
pepsin (compare Fig. 5*1.3- with 5«5.s.)- The difference may
be due either to the fact that in the second experiment the
protein was oxidised with performic acid prior to incubation
with pepsin or to the fact that during the experiments with
E.coli phosphatase the method of electrophoresis was modified.
Originally the contact between the electrode and the electro¬
phoresis paper was via a strip of filter paper soaked in buffer,
but a better separation between the bands was obtained when
the electrodes were placed in buffer reservoirs containing 1
litre of buffer and 3MM filter paper was used as a bridge.
Peak two (Fig. 5«5.a) was eluted, hydrolysed with acid
and subjected to electrophoresis at pH 3.5* The radioactivity
trace showed a double peak, one migrating at the same rate as
■Fig.5.5.a. Radioactivity scan of electrophoresis at pH6.5




Fig. 5.5.b. Radioactivity scan of electrophoresis at pH 3.5
of acid hydrolysis of peak 2 of fig.5.5.a.
phosphate phosphate
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inorganic phosphate and the other parallel to a serine phosphate•
marker (Fig. 5»5.h).
Aliquots of the phosphorylated enzyme were hydrolysed with
hydrochloric acid at 100° for periods from 10 to 90 min., and
then subjected to electrophoresis at pH 3*5» In each case the
radioactivity trace consisted of one peak between the origin
and the phosphate marker. There was no difference in the
relative intensity of the bands with different periods of
v
incubation with acid. Electrophoresis at other pll values of
the phosphorylated enzyme after acid hydrolysis did not achieve
any improvement in the separations.
Electrophoresis of the unhydrolysed material at pH 3*5
and pH 6.5 gave a band of radioactive material with the same
rate of migration as inorganic phosphate and a second peak at
the origin.
Since there remained some doubt as to whether or not the
liver phosphatase had been labelled, an experiment was devised
to test this. Barman and Gutfreund (1966) found that although
the enzyme - phosphate band was stable at pll 5*0, at pH 10.0
inorganic phosphate was liberated. The alkaline phosphatase
32
from liver was incubated with P-phosphate and washed with
acetone-HCl as described previously. Half the precipitate
was dissolved in pH 5»0 buffer and the other half in pH 10.0
buffer and after about 18 hours the protein was precipitated
with acetone and the radioactive phosphate in the supernatant
measured.
Table 5»5 shows the amounts of radioactivity at each stage.
Since more radioactive material was released in the alkaline
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than the acid buffer, it would appear that phosphate had been
incorporated into the enzyme. However, the difference between
the results for the two experiments and the total number of
counts incorporated, is small.
Table Incubation of Phosphorylated Enzyme at two pH
Values.
Expt. A: Phosphorylated enzyme dissolved in pH 5*0 buffer.
Expt. B: Phosphorylated enzyme dissolved in pH 10.0 buffer.





Original incubation mixture 2.1 x 105 2.3 x 105
Supernatant after 2.0 x 105 2.0 x 105
precipitation of labelled
enzyme
First washing 6.8 x 105 6.7 x 105
Second washing 5-3 x 102 6.1 x 102
Supernatant after T.7 10
dissolving in buffer (18
hours)
The method of phosphate incorporation was further investi¬
gated by carrying out the labelling experiment at pH 4-.0, 5*0
and 6.0. In each case about 90% of the radioactivity was
found in the first supernatant. Electrophoresis at pH 3«5
of the acid hydrolysed material gave two bands for the enzymes
labelled at pH 6.0. Allowing the incorporation to proceed
for longer periods of time or increasing the phosphate
concentration did not result in greater yields of phosphory-
- 100 -
lated enzyme.






With the exception of placental phosphatase (Ahmed and
\
King, 1960b) the properties of human alkaline phosphatases
hove generally been studied with unpurified tissue extracts
or sera. When such enzyme sources are used, other enzymes
may interfere with the study of the properties, either by
attacking the substrate or the product of the reaction under
examination, or by altering the enzyme itself. Purified
enzymes are of particular importance in an examination of the
substrate specificity of an enzyme. In order, then, to
eliminate these unknown factors in the study of the properties
of the alkaline phosphatase, steps were taken to obtain
purified enzyme from the tissue extracts.
6.2. RNZYMf PREPARATION.
The yields of enzyme per kg. tissue are 195? 234- and 4-9
units (jamoles pNPP hydrolysed/min.) from liver, intestine and
bone respectively, for the preparations outlined in Table 2.1.
Bone is, therefore, a much poorer source of alkaline phosphat¬
ase than liver or intestine, and this is confirmed by the low
initial specific activity. The bones used were adult ribs:
a better source, though not so readily available, is bone from
young children.
The highest specific activity for the liver and intestinal
enzyme, 165 and- 435 units/mg. protein respectively, can be
compared with those of other workers when their results are
converted into these units by experimental comparison of the
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methods. Ahmed and King (1960a), with human placental
phosphatase, obtained a specific activity of 59 units/mg.
protein, the highest so far for a human phosphatase. 'However,
angstrom (1961a) and Portmann (1957) purified calf intestinal
phosphatase to a specific activity of about 360 units/mg.
protein. The most highly purified alkaline phosphatase is
that of Binkley (1961a), with a specific activity of 14-4-0
units/mg. protein using swine kidney as the source. Without
"recycling gel filtration, the specific activity of the bone
enzyme prepared in the present work remains very much lower
than any of these other values.
As the experiments to estimate the purity of the enzymes
52
by means of ^ P labelling show, the liver and intestinal
enzymes are still contaminated with other proteins. For the
liver enzyme, the main contaminant is probably a haptoglobin-
methaemoglobin complex, as evidenced by its mobility on starch-
gel electrophoresis, peroxidase activity, absorption spectrum
and molecular weight. Barman and Gutfreund (1966) estimated
that their bovine milk alkaline phosphatase preparation had a
purity of 3.6/, and they calculated that the preparation of
Lyster and Aschaffenburg (1962) was 62/ pure. The possible
limitations of the labelling method are discussed below.
Human placental alkaline phosphatase has recently been
purified 4-000-fold and crystallised (Ghosh and Fishman, 1968).
In the present work it was not found possible to improve the
purity of the liver and intestinal enzymes further, and the
question arose as to whether a purity of about 10/ was
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sufficient for kinetic studies to be of value. This represents,
for the liver and intestinal enzymes, a purification of about
2000 and 1000-fold respectively. Ideally, the present work
should have been carried out with enzymes of 100/£ purity,
but attempts to separate them from other proteins of the same
charge and molecular size were unsuccessful. It was not
possible to obtain the bone enzyme in anything like such a
high degree of purity, as has already been noted, since the
fenzyme was present in the tissue of origin in much smaller
amounts. The final enzyme preparations, though far from pure,
were the best that could be obtained.
Slight variations in the conditions of isolation of the
three phosphatases, e.g. the ammonium sulphate concentration
effective in precipitation, do not necessarily reflect differ¬
ences between the isoenzymes, but may instead indicate differ¬
ences in the nature or concentration of the contaminants
(e.g. lipid content).
6.3. APE THE ALKALINE PHOSPHATASES PROM DIFFERahT TISSUES
IDENTICAL?
This question can most readily be answered by comparing
the physical and enzymic properties, and the molecular structure
of the isoenzymes.
6.3*1• Physical Properties.
Molecular weight: The similarity of the molecular weights of
the three phosphatases (220,000, 195»000 and about 200,000 for .
the liver, intestinal and bone enzymes respectively) found in
the present work is confirmed, by the results of Birkett et al
(1965) who found that the isoenzymes all had the same elution
volume on "Sephadex G-200". Boyer (1965) found that the
kidney and placental enzymes had molecular weights of about
150,000, as measured by ultracentrifugation. Recently, the
molecular weight of one of the variants of the placental
enzyme has been shown to be 70,000 by ultracentrifugation;
another variant is thought to be an aggregate of this and
have a molecular weight of over 200,000 (Ghosh and Fishman,
1967). There thus appears to be some variation between the
molecular weight as measured by gel-filtration and by ultra¬
centrifugation. However, Andrews (1964) found that molecular
weights measured by the method of gel-filtration never varied
by more than 10% from the ultracentrifugation results.
The effluent volume on gel-filtration is in fact not so
much dependent on molecular weight as on the shape and size
of the molecule, for the rate at which molecules pass through
a gel is inversely proportional to the fluid volume accessible
to them within the column. However, within a group of macro-
molecules, size and molecular weight are closely related
(Andrews, 1962). In a later paper Andrews (1964) suggested
that, if a protein contains a large quantity of carbohydrate,
it may have a more expanded form than proteins which do not
contain carbohydrate; this would give a. higher result for
molecular weights measured by gel-filtration. The results
of experiments with neuraminidase suggest that the intestinal
enzyme contains less carbohydrate, or at least less carbo¬
hydrate susceptible to the action of neuraminidase, than the
bone and liver enzymes. If there were sufficient carbohydrate
to affect the molecular weight measurement then the intestinal
enzyme would have a smaller molecular weight. Andrews (1964)
quoted as the upper limit to include variation due to carbo¬
hydrate content and this would give a molecular weight for
the liver enzyme of 198,000. However, the amount of carbo¬
hydrate is probably not sufficient to affect the elution
volume, and Saraswathi and Bachhawat (1968) found that removal
w
of sialic acid from sheep brain alkaline phosphatase had no
effect on the molecular weight, as measured by gel-filtration.
If the figures obtained by gel-filtration are true estimates
of molecular weight, there would appear to be a slight differ¬
ence between,the liver and intestinal enzymes. The bone
phosphatase probably resembles the liver enzyme more closely
than the intestinal enzyme.
Mobility on starch-gel electrophoresis: The main bands of the
tissue extracts from liver, bone and intestine have mobilities
similar to those found by Moss and King (1962) and by Hodson
et al (1962). The slow band which Moss and King (1962) found
in each of their preparations and which was presumed to be an
enzyme-lipoprotein complex (Moss, 1962) was also seen in the
present work. The band with intermediate mobility observed
by Moss and King (1962) m liver phosphatase was not found.
V/arnock (1966) reported similar patterns following starch-gel
electrophoresis, and she observed a nd of intermediate
mobility with bone phosphatase also. This appears to
correspond in relative position to the zone of activity which
was found in the present work with bone extracts which had
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been stored for long periods. Warnock (1966) also confirmed
that the slow "lipoprotein" bands in each tissue were of a
similar nature as the main band by L-phenylalanine inhibition
and heat inactivation.
Differences in mobility in starch-gel electrophoresis
are partly governed by the size of the molecule and partly
by its charge. Smithies (1962) devised a method for disting¬
uishing which of these factors was the main cause for differ¬
ences in mobility of two or more proteins by submitting them
to electrophoresis in starch-gel having different concentrations
of gel, but this type of experiment was not performed in the
present work.
Recently, Smith, Lightstone and Perry (1968) were able
to separate a mixture of bone and liver phosphatase on
acrylamide-gel electrophoresis.
Reaction to neuraminidase: Robinson and Pierce (1964) suggested
that intestinal phosphatase was insensitive to the action of
neuraminidase whereas the other alkaline phosphatases found in
normal serum were sensitive. It was confirmed, in the present
work, that the mdbilities on starch-gel electrophoresis of both
the main band and the minor band of liver and bone phosphatases
were altered after incubation with neuraminidase both in the
early and in the final stages of preparation. The intestinal
phosphatase was insensitive. Alkaline phosphatases from
various other human tissues have recently been shown to be
sensitive to neuraminidase, including enzymes prepared from
placenta (Robinson, Pierce and Blumberg, 1966), kidney
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(Butterworth and Moss, 1966) and lung (Smith et al, 1968).
.Recently Saraswathi and Bachhawat (1968), working with sheep
brain alkaline phosphatase, found two distinct phosphatases
in the same tissue. These differed in their sialic acid
content and although treatment with neuraminidase reduced
the mobility of the faster fraction to the mobility of the
slower, other properties, e.g. substrate specificity, were
still dissimilar.
The product of neuraminidase action on placental
phosphatase has been shown to be sialic acid by the absorption
spectrum of the complex formed from the reaction of sialic
acid with thiobarbiturate (Ghosh, Goldman and Fishman, 1967).
Hobson and Harris (1966) have produced up to eight bands of
alkaline phosphatase activity with human placental phosphatase
acted on by graded neuraminidase concentrations.
The results show that the intestinal phosphatase on the
one hand and the liver and bone phosphatases on the other differ,
either in sialic acid content or in the availability of the
sialic acid to the action of neuraminidase. However, the
differences in mobility on starch-gel electrophoresis cannot
be solely due to differences in sialic acid content, for the
electrophoretic migrations of the liver and bone enzymes do
not become identical following treatment with neuraminidase,
and both enzymes then migrate more slowly than the intestinal
enzyme.
Since the amount of sialic acid is probably small, as
judged by the finding of 1-2% sialic acid in placental phos¬
phatase (Fishman and Ghosh, 1967b, p.312), removal of sialic
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acid would not be expected to effect much change in the size
of the molecule. Consequently, it is likely that differences
in mobility on starch-gel electrophoresis following neuramini¬
dase treatment, are mainly due to alterations in charge and
not to reduction in the size of the molecule. It is probable,
therefore, that the differences in mobilities of the enzymes
prior to neuraminidase treatment are due to differences in the
total charge of the molecules. This would mean that there are
differences either in amino acid residues with charged side-
chains (e.g. aspartic acid) or in charged non-protein parts
of the molecule.
Since there is no Change in the enzymic activity after
treatment with neuraminidase, the sialic acid residues do not
play a vital role in the hydrolytic action of the phosphatases.
Inactivation under various conditions: The rate of inactivation
during heating of the phosphatases was found, in this work, to
be greatest with bone phosphatase, and least with' the intest¬
inal enzyme. Although there were considerable variation in
the rate for each phosphatase with minor changes in temper¬
ature, the general pattern was consistent. This has been
confirmed by Warnock (1966). The much greater stability of
the placental phosphatase to heat has been noted by Neale
et al (1965) and by Fishman, Inglis, Sarke and Ghosh (1966).
Moss and King (1962) found the intestinal enzyme to be slightly
less stable than the liver enzyme. This is not in agreement
with the results found here, nor with the findings of Warnock
(1966). Slight variation in the temperature of inactivation,
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if the inactivations are not carried out in parallel, could
account for this discrepancy.
The order of increasing stability towards urea wag the
same as for thermal inactivation, namely, bone, liver and
intestinal phosphatase. Rapid increase in the rate of
inactivation by urea with temperature was also seen. Other
workers have found that kidney phosphatase is slightly more
rapidly inactivated by urea than the liver enzyme (Butterworth
dnd Ross, 1967) and that placental enzyme is more stable than
the intestinal enzyme (Birkett et al, 1965). ihe critical
concentration of urea at which denaturation changes from
reversible to irreversible observed by Callaghan and Nartin
(1962 and 1965) using albumin has also been noted by Birkett,
Conyers, Neale, Posen and Brudenell-Woods (1967) with human
alkaline phosphatases. At urea concentrations below about
1.5H for the bone phosphatase and 4-M and 8K for the intestinal
and placental enzymes respectively, urea inhibits by a mechanism
which has been interpreted as due to unfolding or conformational
changes in the molecule, caused by binding of the urea at sites
other than at the catalytic centre. At urea concentrations
above the critical value, denaturation of the enzyme is
probably taking place with rupture of hydrogen bonding
(Birkett et al, 1967).
At acid pH the order of increasing stability is bone,
liver and intestinal phosphatase. Scutt and Floss (1968)
found, by bringing the pH back to pH 7.2 after acid inactivation,
that the liver and intestinal phosphatases could be reactivated.
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However, the degree of reactivation depended on the pH of
inactivation and on the length of time that the enzymes had
been exposed to low pH. The kinetic properties, e.g. -Tlich-
aelis constant, of the reactivated enzyme differed from the
original value with intestinal phosphatase, but showed no
change with the liver enzyme. If the intestinal phosphatase
was partially inactivated, this intermediate form had the same
kinetic characteristics as the enzyme which had been completely
inactivated and then allowed to reactivate. They concluded
that there were at least two stages in the inactivation of
the intestinal isoenzyme, the first of these being rapid and
the second slower. On the other hand, swine kidney phosphat¬
ase can be completely inactivated at acid pH and reactivated
at neutral pH without showing any change in electrophoretic
and gel-filtration properties (Sutterworth, 1968).
Reynolds and Ochlesinger (1967) found that, when R.coli
phosphatase was inactivated at pH 2.0 and 0°, two inactive
subunits with extended coil shape were produced. If the pH
was then raised to pH 4.0, the subunits began to take up a
more globular shape, but were still inactive. Raising the
pH to 6 to 8 for one minute at 20° caused refolding of the
subunits to give a monomer with the same content of -helix
as the native enzyme but with no enzymic activity; more
prolonged incubation at pH 6-8 and 20° and in the presence of
zinc ions, resulted in the formation of a dimer which was
indistinguishable from the original enzyme molecule. Although
the human phosphatases are not known to consist of subunits,
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it would seem possible that they may be made up of four such
units, since the molecular weight of the human enzymes is
approximately twice the value for the S.coli phosphatase.
The differences in stability tov/ards acid conditions could
be due to differences in the binding of the subunits, and in
the structure of the subunits themselves.
The marked differences between the phosphatases in
stability towards these three denaturing agents indicates that
there are fundamental differences between them. Although
the order of stability is the same in each case, the mechanism
of inactivation and the cause of the dissimilarity between the
phosphatases is not necessarily the same. Some form of
intramolecular bonding is presumably being disrupted by these
conditions and it would appear that the placental enzyme has
the strongest bonding and that from bone the weakest. The
nature and strength of the bonding will, in turn, be related
to the amino acid sequences of the isoenzymes.
Immunological Properties: A recent development in the immunol¬
ogical study of the alkaline phosphatases has been the work of
Sussman, Small and Cotlove (1968). When an antibody to
purified human liver phosphatase was made, it cross-reacted
only with the liver enzyme and not with bone, placental, kidney,
intestinal, nucleophilic or E.coli phosphatases. Similarly
the anti-placental phosphatase antibody only precipitated the
placental phosphatase. They concluded that there were at
least three antigenic types of phosphatase, i.e. liver,
placental and one or more from the other enzymes, and suggested
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that the antigens used in previous studies had been mixtures
which had resulted in the simultaneous induction of several
antibodies and the conclusion that there was apparently common
antigenicity. Smith et al (1968) suggested that the cross-
reaction previously found between anti-liver phosphatase
antibody and bone and kidney phosphatases (e.g. by Boyer,
1963) might be due to the fact that most tissue preparations
contain a certain amount of blood which cannot be removed by
V- x
washing and, since the main isoenzyme in serum is from the
liver, all preparations were contaminated with small quantities
of liver enzyme. As intestine is relatively free from blood
the phosphatase would have a smaller interaction with the anti¬
body to the liver enzyme. It would appear probable, therefore,
that each isoenzyme will be shown to be immunologically distinct.
6.3*2. Rnzymic Properties.
Substrate Specificity: Although pyrophosphatase and alkaline
phosphatase activities have been thought to be closely associated,
they have not always been considered to be functions of the same
enzyme protein (Roche, 1950; Morton, 1955)• The findings of
Heppel et al (1962) and of Trubowitz et al (1961), however,
suggested that the two activities might be associated. Since
the start of this work more evidence has accumulated which
attributes pyrophosphatase activity to alkaline phosphatase.
In 1965 Russell found an association between low plasma and
tissue levels of alkaline phosphatase and an elevated excretion
of inorganic pyrophosphate. Calf intestinal alkaline phospha¬
tase has been found to hydrolyse inorganic pyrophosphate
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(Fernley and .Valker, 1967; Fernley and Bisaz, 1968). Human
leucocytes (Cox and Griffin, 1965), a culture of human cells
(Gox, Gilbert and Griffin, 1967) and human -placenta (oussman
and Laga, 1968) have each been found to contain an alkaline
phosphatase which also hydrolysed inorganic pyrophosphate.
The only alkaline phosphatase which has recently been shown
to have no pyrophosphatase action is that from human neutro¬
phils (Huser and Olderding, 1967). However, the enzyme
v
preparation of these workers was also inactive towards. AMP
which has been recognised as a substrate for alkaline
phosphatase for some time. The evidence presented here,
e.g. mixed-substrate experiments and the position of the
zones of activity with different substrates after starch-gel
electrophoresis, as well as the observations of other workers,
that human liver, intestinal, placental and bone alkaline
phosphatases are also pyrophosphatases, would appear to be
fairly conclusive.
The ratio of inorganic pyrophosphatase to orthophosphatase
activity differs by a factor of five or six between the intest¬
inal enzyme on the one hand, and the liver and bone phosphatases
on the other. The slight variation in the ratio between the
bone and liver enzymes may or may not be significant, but the
intestinal enzyme must be considered as different from the
other two enzymes in this respect. As with the effect of
neuraminidase, the isoenzymes may thus be divided into two
groups on the basis of their relative activities towards
inorganic pyrophosphate.
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When the relative rates of hydrolysis of various nucleo¬
tides are compared, it can be seen that again the intestinal
phosphatase differs more from the liver and bone enzymes than
the latter do from each other (Table 4.2). The low ratio
of orthophosphatase to inorganic pyrophosphatase activity for
intestinal phosphatase is reflected in the high relative rates
of hydrolysis towards ADP and UDP. Apart from the hydrolysis
of AMP by the intestinal enzyme, the nucleoside monophosphate
v
esters are hydrolysed less rapidly than pNPP. But it would
appear that the active centre of the molecule is relatively
non-specific for the non-phosphate part of the substrate
molecule, once this has reached a certain size, for there is
a marked similarity between the relative rates of hydrolysis
with the corresponding adenine and uracil derivatives, part¬
icularly with the bone enzyme. The relatively rapid rate of
hydrolysis of AMP by the intestinal enzyme has already been
noted (Landau and Gchlamowitz, 1961) and, though difficult to
explain, it does re-emphasise the fact that the intestinal
phosphatase appears to differ from the liver and bone enzymes.
A possible explanation of why Morton (1955) was unable to
detect pyrophosphatase activity in his enzyme preparations may
be that he used a 10mM magnesium concentration which, from the
results found here, would completely inhibit the pyrophosphatase
activity. Differences in stability between pyrophosphatase
and orthophosphatase activities in extracts of pig liver were
suggested as evidence for the non-identity of the two activities
(Roche, 1950), but such differences were not found with the
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human phosphatases. Anderson and Nordlie (1967), working with
A.coli phosphatase, attributed differences in heat stability
with different substrates to the possibility that the non-
phosphate part of different substrates might bind to different
sites in the protein molecule and a difference in stability
did not, therefore, preclude the two activities being properties
of the same enzyme molecule.
Affect of fetal Ions: In common with most enzymes acting on
phosphorylated substrates, the hydrolysis of orthophosphates
by alkaline phosphatase is a.ctivated by the addition of
magnesium ions to the assay s:/stem. Gince Mn^+, or to a
0_|_ p_j_
lesser extent Gs.c~ , may substitute for Kg "r in the activation
(Norton, 1957; Ahmed, Abul-fadl and King, 1959), and since
the concentration of metal ions is not dependent on the sub-
2+
strate concentration, the activation by Kg T is probably non¬
specific. However, when inorganic pyrophosphate is the
substrate a relative concentration of substrate to magnesium
of about 2:1 is optimal.
With the inorganic pyrophosphatase from rat erythrocytes
(H.C.5.6.I.1.) the rate of hydrolysis of inorganic pyrophosphate
increased with increasing magnesium ion concentra.tion to at
least 7niM and, in this case, the true substrate was thought to
be a magnesium-substrate complex, (Kg Po0r7)'1 . An increase
in Ng^+ thus produced an increase in the amount of true subs¬
trate present, and hence an increase in velocity (Bloch-
Prankenthal, 195A). However, the relationship between magne¬
sium concentration and the rate of hydrolysis with the pyro-
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phosphatase activity of human alkaline phosphatase does not
follow this pattern and, unlike the rat erythrocyte enzyme,
there is some phosphatase activity in the absence of added
magnesium. fhe mechanism of action of Mg^+ is, therefore,
unlikely to be by the formation of (Fig P2O7) ~ •
The effect of magnesium on the hydrolysis of orthophos-
phates and of inorganic pyrophosphate does not vary with the
source of the enzyme, with the possible exception that higher
fates of hydrolysis were observed with pNPP and intestinal
phosphatase (Table 4.4). This may be due to res'idual Fg +
in the enzyme solution, but it may on the other hand represent
a geruine difference between the isoenzymes since the enzyme
solutions were dialysed before use. with the organic pyro¬
phosphates, there is a greater difference between the iso¬
enzymes, but this does not follow a definite pattern. (Pig.
4.13 and 14 and Table 4.2.).
when zinc ions are added, the low optimum concentration
indicates that the metal is not forming a metal-substrate
complex. This would be consistent with the suggestion of
many workers that a metal ion, probably zinc, is a constituent
of the G.coli alkaline phosphatase molecule (Garen and Levinthal,
1960; Plocke et al, 1962; Plocke and Vallee, 1962; Reynolds
and ochlesinger, 1967). Recently, Pishman and Ghosh (1967a)
have produced evidence to suggest that a metal, probably zinc,
plays a functional role in the catalysis of the hydrolysis of
phenyl phosphate by rat intestinal phosphatase.
Gonyers, Birkett, Neale, Posen and Brudenell-V/oods (1967)
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studied the effect of EDTA on the hydrolysis of phenyl phos¬
phate by human bone, intestinal and placental alkaline phos¬
phatases, and found three effects. At low concentrations of
GDTA (10~5 - 10"3M) in the assay system, there was an instant¬
aneous inhibition of the activity of each phosphatase, possibly
due to the removal of some activator which was contaminating
the enzyme preparation. As the concentration of the EBTA in
-8 -1
the assay system was increased from 10 ri to 10 N, however,
a progressive inhibition was seen with the bone and intestinal
enzymes only; the placental phosphatase was activated under
these conditions, and they attributed the inhibitory effect
observed to chelation of a divalent cation necessary for
activity of the bone and intestinal enzymes. The third effect
observed by Gonyers et al (1967) was a time-dependent inacti-
vation, not reversed by dilution, which occurred when the
enzyme was preincubated with GDTA; all three phosphatases
exhibited this inactivation, but the rates of inactivation
differed, and they attributed this inhibition to the removal
or binding of a functionally essential metal, probably zinc.
The approximately 100-fold difference between the concen¬
tration of zinc which inhibits the orthophosphatase and pyro¬
phosphatase activities is difficult to explain and a full
investigation using enzyme preparations which have been
previously inactivated by dialysis against a metal-chelating
agent might help to clarify this problem.
The total evidence, however, suggests that the human
alkaline phosphatases are metallo-enzymes.
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Kinetics of the Hydrolysis -Reaction: Although the effects of
high substrate concentration are different with orthophosphate
and pyrophosphate substrates, there appears to be littl'e differ¬
ence between the effects with liver and intestinal phosphatases.
(Fig. 4-.15 and 4.16). Similarly, only a small difference between
the R values can be seen although there is a tendency to higher
values with liver phosphatase (fable 4.5). Moss et al (1961a)
found a reproducible difference in K values for the human1 m
enzymes when the velocities were measured at the optimum pH
for each substrate concentration. When the -plots of pK^ - m
against pll for orthophosphata.se activity (Fig. 4.19) are
studied, it can be seen that at any one t>H value the K for' * m
the phosphatases from different tissues are dissimilar and
again the liver enzyme has higher values than the bone or
intestinal phosphatase.
.Che "Dixon plots" of pK against pH for orthophosphatase
activity show that the pKg values for the three phosphatases
with pNPP (8.5 to 8.8) are only slightly different. It is
probable, therefore, that human bone, liver and intestinal
phosphatases all have the same amino acid residues involved
in the binding of pNPP to each enzyme, and that the ionic
environment of these residues is the same. pK values for
human placental phosphatase with phenyl phosphate as substrate
have been found to be 9-3 and 9.9 for the free enzyme, and
9.7 and 10.5 for the enzyme-substrate complex (Fishman and
Ghosh, 1967b, p.275). If a line of unit slope is fitted
to the data of Fishman and Ghosh, a pK^ of about 9-2 and a
oK of 10.4 are obtained. When deriving the pK for calf1 es 0 x e
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intestinal phosphatase and cow's milk phosphatase, using phenyl
phosphate as substrate, Norton (1957) fitted lines of unit
slope and found that the pK^ with both enzymes was about 9.2.
Ghosh and Fishman (1966), on the other hand, found a. pK^ of
8.6 with rat intestinal phosphatase and phenyl phosphate;
this value becomes 8.5 if lines of unit slope are fitted.
It would appear, then, that the pK values generally vary
both with the substrate used and with the tissue used as
source of the enzyme.
The variations in pK with substrate and with source arer e
again seen when the graphs of pK^ against pH, with inorganic
pyrophosphate as substrate, are studied (Fig. 4-.20 and Table
4-.6). The differences in the pKg values for the three phos¬
phatases could mean that different amino and residues in each
phosphatase were combining with the substrate. However, it
would seem more likely that the amino acids involved are the
same, and that the pK. values are different due to differences
in the ionic environment. The pK values- for pyrophosphatase0 S
activity also differ for the three phosphatases, and increase
in the order liver phosphatase, bone phosphatase and intestinal
phosphatase. These findings also probably indicate differences
in neighbouring amino acid groups rather than differences in the
active centre itself. The bone and liver enzymes may have a
second pK value analogous to the value found for the intest-* es -1
inal enzyme. However, this second value would lie below pH
7.0, which is outside the pll range in which measurements can
be made. Unlike some of the other differences between the
isoenzymes, such as neuraminidase sensitivity and substrate
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specificity, the isoenzymes cannot be divided into intestinal
and non-intestinal groups of enzymes on the basis of pKo and
pK values, since they each show different characteristics.
A comparison of the values or affinities for the two
substrates (Table 4.7) shows that, at pH 7»0, the affinity of
each enzyme is the same for both substrates. It is probable
that the phosphate part of the substrate is binding to the
enzyme molecule at this pH, while at a higher pH the attach¬
ment of the organic part assumes greater importance. The pKg
at 3.3-8.5? observed when pNPP is used as substrate, is not
involved in the binding of pyrophosphate since no discontin¬
uity occurs at this pH in the plots for pyrophosphatase
activity (Pig. 4.20).
Plots of log V against pH indicate oK values for the° max °
enzyme-substrate complex. Then inorganic pyrophosphate is
the substrate the pK values obtained from the graphs of0 S
pK and log V against pH (Fig. 4.20 and 4.22) do not matchjr m o max o . x \ o
very closely. The comparison of V values at different pHd x max r
values (Table 4.8) shows that, below pH 8.0, alkaline phosphat¬
ase is equally effective a pyrophosphatase as an .orthophosphat-
ase •
Inhibition of t'ae hydrolysis Reaction: On the basis of their
sensitivity to L-phenylalanine, the isoenzymes can be divided
into two classes, intestinal and non-intestinal. The fact
that both the pyrophosphatase and the ox^thophosphatase activities
of the intestinal enzyme are inhibited, whereas the liver and
bone phosphatases are not affected supports the theory that
both activities are properties of the same enzyme molecule.
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Since the values are identical with both substrates, it is
likely that L-phenylalanine is combining at the same site in
the enzyme molecule when acting as an inhibitor of either the
pyrophosphatase or the orthophosphata.se activities. L-pheny¬
lalanine has recently been shown to inhibit human placental
phosphatase, the inhibition being uncompetitive in type (Fish-
man et al, 1966), and on the basis of its sensitivity to
phenylalanine the placental isoenzyme falls into the same group
as intestinal phosphatase.
Fishman and Ghosh (19&7b, p.285) found the inhibition of
human intestinal and placental phosphatases by L-phenylalanine
to be uncompetitive, but the present work on intestinal phos¬
phatase indicates that the inhibition is non-competitive in type.
Differences in the experimental conditions included the use of
different substrates, and the addition, by Fishman and Ghosh,
of D-phenylalanine to the control tubes.
the difference between non-competitive and uncompetitive
inhibition lies in the mechanism of formation of the inhibitor -
enzyme - substrate complex (LIS). With non-competitive
inhibition, either an enzyme - inhibitor complex (LI) or an
enzyme-substrate complex (S3) may be formed first, but in
uncompetitive inhibition LIS is only formed via ES. The
nature of the substrate should, therefore, have no effect on
type of inhibition in these experiments with intestinal
phosphatase, since the point at issue is whether or not the
inhibitor can combine with the enzyme. The D-isomer of
phenylalanine causes slight activation of alkaline phosphatase
(Ghosh and Fishman, 1966) and this might affect the results,
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leading to a different interpretation of type of inhibition,
although this seems unlikely. A precise comparison of the
methods with the two intestinal preparations would be Accessary
to clarify this problem.
Ghosh and Fishman (1966) found that the activation energy
in the presence of L-phenylalanine was about three times the
value observed in the presence of the D-isomer. They inter¬
preted this finding as meaning that the inhibitor had
combined with the ES complex to give an inactive, thermodyemic-
ally stable CIS complex with a consequent reduction in the
amount of AS present. The results are, however, also compat¬
ible with non-competitive inhibition, when the inhibitor can
combine with the enzyme.
The affinity of arsenate for the enzyme is the same irres¬
pective of the tissue source of the enzyme and the substrate
used (Table A.9). The isoenzymes cannot, therefore, be
distinguished on the basis of. their inhibitor constants with
arsenate.
Since the inhibitor constants at pfl 8.9 for the inhibition
by arsena.be and L-phenylalanine are the same for both the
orthophosphatase and pyrophosphatase activities, it would seem
likely that both activities are located at the same site in
the enzyme molecule.
Catalytic - centre Activity: The investigation of the catalytic-
centre activity of tae liver and intestinal phosphatases
revealed differences between them. The very low dissociation
constanb found with the liver enzyme indicates that the equili-
- 124 -
briu'm is very strongly in favour of the enzyme-phosphate
complex. Barman and Gutfreund (1966), working with a prepar¬
ation of bovine milk phosphatase, reported that the catalytic-
centre activity with pNPP was 2700 sec. . In the present
-1 -1
■work, the activities were 5030 sec. ana 6550 sec. for the
liver and intestinal phosphatase respectively; this is of
the same order as the value reported for the bovine enzyme,
if allowance is made for the fact that the activity of the
bovine enzyme was measured at 25° whereas the human phosphatases
were investigated at 37°•
This method of estimating the catalytic-centre activity
and investigating the purity of the enzyme preparation assumes
that phosphate is binding at the catalytic-centre and that
all the sites are equally and completely labelled. The former
assumption is justified because phosphate is a competitive
inhibitor of the action of alkaline phosphatase, and because
52
the incorporation of y P is much reduced in the presence of
substrate or heat-inactivated enzyme. Verification of the
latter assumption would require detailed chemical studies of
amino acid sequences.
6. 3 ♦ 3 • I'lolecular Structure.
One method of studying the active centre of the phos¬
phatases is to measure the activity of the enzymes in the
presence of substances which are known to combine with parti¬
cular groups in protein molecules. Recently, Fishman and
Ghosh (1967a.) applied this method to the st\idy of rat intest¬
inal phosphatase, and concluded that thiol groups and the
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£-amino group of lysine participated in the catalysis.
Whether this is also true of the human enzymes remains to be
investigated.
Fi slaman and Ghosh (1967b, p. 282) proposed a mechanism
for the hydrolysis of monoesters involving the metal ion,
the sulphhydryl group and the C-amino group of lysine. They
suggested that the substrate becomes attached to the enzyme
by co-ordination between the lone pair of electrons on the
bridge oxygen and the metal and between one of the electron-
rich ionic oxygen atoms and the metal. The other ionic
oxygen is attracted to the£-amino group while the double
bonded oxygen becomes hydrogen bonded with the hydrogen-
donating site of the sulphhydryl group (Fig. 6.1.). Nucleo-
philic attack by the hydroxyl ion of the medium on the phos¬
phorus atom causes release of the alcohol and formation of
the phosphoryl enzyme, which subsequently breaks down to
inorganic phosphate and free enzyme. This suggested mechan¬
ism onl:/ takes account of the groupings thought to be directly
involved in the catalytic reaction, and does not take into
consideration any conformational changes in the enzyme mole¬
cule which may occur (Fernley and Walker, 1965; Barman and
Gutfreund, 1966).
The attempts to investigate the amino acid sequence
around the active sites of the human phosphatases were not
successful, although it was possible to label and subsequently
hydrolyse the F.coli phosphata.se. There may be several reasons
for this failure. It is possible that the enzyme was labelled
but that the hydrolytic reaction was not effective and the
Dig. 6.1. Diagram
Ghosh. (1967b) for
of the mechanism postulated by Dishman and
the formation of the enzyme-substrate complex.
f C
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small number of fractions seen as peaks after scanning the
electrophoresis strips would suggest this (Fig. 5«1 5-5) •
However, when the material, which had been incubated with
acid, was dialysed and the fraction on the outside of the
dialysis bag subjected to electrophoresis both the peaks
observed (Fig. 5.2a) cannot represent free ' P-phosphate and
one would conclude that the other peak is a peptide or amino
52
acid laoelled with ^ P. Recently Goldsmith and Robinson
(1968) found that human serum alkaline phosphatase was very
resistant to protease action.
On the other hand, it is possible that the enzymes have
not been labelled, and that the peaks seen after electrophor¬
esis represented free radioactive phosphate together with
phosphate absorbed on to contaminating proteins. The
concentration of the enzyme was estimated to be not more than
1b of the total protein present and it may have been consider¬
ably less. This small amount of alkaline phosphatase may have
meant that there was not sufficient; present for it to become
52
labelled with P. The conditions necessary for labelling
may also be different for the human enzymes. However, it
52
proved possible to incorporate P into the phosphatases when
the catalytic-centre activities of the enzymes were being
measured. Several groups of workers have recently labelled
n.coli phosphatase (Pigretti and Milstein, 1965; Fernley and
Halker, 1966), bovine milk phosphatase (Barman and Gutfreund,
1966^ and calf intestinal phosphatase (Fernley and Bisaz,
1968). The method is, therefore, practicable for several
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different phosphatases and it would appear necessary to repeat
the experiments with the human enzymes with slight variations
both in the conditions of labelling and of hydrolysis and with
a greater concentration of enzyme protein. Co far it has not
been possible to learn anything from these experiments about
the amino acid sequence at the active centre of the human
alkaline phosphatases.
6.3• 4-• Conclusions on the Identity of the Alkaline Phosphatases.
The main differences between the alkaline phosphatases
are summarised in Table 6.1. On the basis of physical
properties there are four ways in which the isoenzymes differ:
mobility on starch-gel electrophoresis, sensitivity to neura¬
minidase, rates of inactivation, and antigenicity. There
are also differences in the main enzymic properties in terms
of substrate specificity and the effects of inhibitors.
It would appear from the investigation of substrate
specificity and from the kinetic experiments that the active
centres of the isoenzymes are different. It is, however,
unlikely that the amino acid sequences immediately around
the active serine differ, since both E.coli phosphatase and
bovine liver phosphatase have the same sequence at this point.
The differences in the active centres are, therefore, probably
due to variation in the amino acid residues at points in the
enzyme molecule which, although remote from the active serine
in the amino acid sequence, nevertheless are closely related
to it in space by virtue of the tertiary structure of the
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the fact that the differences in the electric charge carried
by the isoenzymes cannot wholly be accounted for on the basis
of their sialic acid content, and probably results from,
differences in amino acid residues with charged side-chains.
It has already been suggested that the insensitivity of
intestinal phosphatase to neuraminidase results from inaccess¬
ibility of its sialic acid to the action of neuraminidase.
If this is the case, then the intestinal enzyme must have a
different tertiary structure from the liver and bone enzymes,
which would in its turn probably indicate a. difference in the
primary structure of the phosphatases. .Differences in the
folding of the intestinal phosphatase molecule could also
account for the fact that, in contrast to the liver and bone
enzymes, the intestinal enzyme is inhibited by L-phenylalanine.
irishman and Ghosh (1967b, p. 284-) suggested that alkaline
phosphatase could exist in a certain physical state in the
membranes of the striated border and that it was this native
form of alkaline phosphatase which was inhibited by L-pheny¬
lalanine. fhus a tissue with microvilli active in absorption
(i.e. intestine and placenta) would have alkaline phosphatase
in the physical configuration necessary for L-phenylalanine
inhibition. Since the intestinal and placental phosphatases
vary in other properties such as heat sensitivity and sensit¬
ivity to neuraminidase this cannot be the sole difference
between the isoenzymes. The great variation in stability
towards heat, urea, and low pH could be accounted for on the
basis of differences in tertiary, and hence primary, structure
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of the enzyme molecules.
It thus appears that the human isoenzymes of alkaline
phosphatase are different, and that the differences result
from dissimilarities in the protein molecules at several
levels of protein organisation. further investigations
are needed, particularly amino acid sequence determinations,
if the differences are to be more precisely defined.
The question whether the production of the isoenzymes
Of alkaline phosphatase is controlled by different genes, or
whether just one basic structure is formed for the alkaline
phosphatases and this subsequently modified in different
tissues requires consideration. Robson and Harris (1965)
found six distinct phcnotypes, from a study of the electro-
phoretic patterns of extracts of placenta, and from twin
studie.s they concluded that the polymorphism of placental
alkaline phosphatase was due to the existence of three
autosomal allelic genes. There is evidence to suggest that
the production of intestinal phosphatase is also genetically
controlled. The appearance of an intestinal band in the
starch-gel electrophoresis pattern of serum from certain
individuals has been linked with the ABO blood groups and
with gastric secretor status (Cepellini, 1960).
Within the non-placental, non-intestinal group of
alkaline phosphatases (i.e. those from liver, bone, kidney
etc.) differences between isoenzymes are less clear cut, and
it would seem possible that the variations might be the
result of environmental factors. In cases of hypophoophat-
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asia, a genetic disease which, results in deficient bone
mineralisation, it has been suggested that the alkaline
phosphatase level in all tissues is depressed (e.g. dchl.es-
inger, Ludar and Bodan, 1955)• However, a case with hypo-
phosphatasia in which both the liver and duodenal juice
alkaline phosphatases were normal has been reported,
although in this instance cells from a tissue culture of bone
showed an abundance of alkaline phosphatase activity (Ccag-
lione and Lucey, 1956)• in a recently reported series of
cases of hypophosphatasia, the intestinal phosphatase was
found to have either a normal or raised level (Danovitch,
Baer and faster, 1968). This would indicate the existence
of separate genetic controls for bone, liver and. intestinal
phosphatases as well as for the placental enzyme, if the
defecb in hypophosphatasia is genuinely a genetically-
controlled failure to produce alkaline phosphatase.
6.4. THa PHYSIOLOGICAL ROhb OF ALK.ALIK5 PHOSPHATASE.
The discovery by Robison and Soames (1924) that the
immersion ox bone tissue in a solution of calcium hexose
monophosphate produced a deposit of calcium phosphate led to
the suggestion that alkaline phosphatase played a role in bone
mineralisation. Robison (1932) suggested that the enzyme
induced calcification of bone by producing a. local increase in
phosphate concentration and, by the law of mass action,
precipitation of calcium phosphate. This "booster" theory
failed when it was found that extraneous tissues were normally
supersaturated with respect to bone mineral (Neuman and
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Neuman, 1958) and that; collagen could trigger the formation
of calcium phosphate crystals (Fleisch and neuman, 1961).
Fleisch and Neuman (1961) have suggested that an inhibitor
might act to prevent calcification of some collagen tissue.
They found that plasma contained an inhibitor which, in
vitro, prevented precipitation of calcium salts and which was
destroyed by alkaline phosphatase. the inhibitor was later
identified as inorganic pyrophosphate (Fleisch and 3isaz,
1962). Inorganic pyrophosphate also prevented the mineral¬
isation of chick embryo femurs grown in tissue culture
(Fleisch, et al, 1964-). From his finding that there was an
increased urinary excretion of inorganic pyrophosphate in
hypophosp'natasia, Russell (1965) suggested that the defective
bone mineralisation characteristic of this disease resulted
from the low alkaline phosphatase level, and the consequent
excessive inhibition of calcification by pyrophosphate. The
discovery that human bone alkaline phosphatase acts as a
pyrophosphatase supports this theory.
Recently, Jibril (1967) proposed that alkaline phosphatas
might in fact have several functions in bone tissues, such as
the production of a local accumulation of phosphate for minera
isation, the production of inorganic phosphate for re-utilis¬
ation in energy-producing reactions, and a control action
involving limitation of the accumulation of inhibitors of
calcification in tl 3 zone of active mineralisation.
With the discovery of the pyrophosphatase action of
alkaline phosphatase, new light has been shed on the function
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of bone phosphatase, but very little is known about the role
of the other phosphatases. It has been suggested that the
alkaline phosphatase which occurs in nuclei may play a-role in
nucleic acid synthesis by hydrolysing pyrophosphate which is a
product of the reaction and which inhibits nucleic acid synth¬
esis. the enzyme may also be involved in the phosphorylation
and dephosphorylation of nuclear proteins (Cox, Gilbert and
Griffin, 1967). Cox and Griffin (1967) suggest that the
main function of intestinal and kidney alkaline phosphatases
ma;/ be as phosphotransferases rather than as phosphatases,
physiological roles for alkaline phosphatases from tissues
other than bone can, therefore, only be postulated and
further investigation is obviously necessary.
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